ArticlePDF AvailableLiterature Review

Electrical stimulation-based bone fracture treatment, if it works so well why do not more surgeons use it?

Authors:

Abstract and Figures

Background Electrical stimulation (EStim) has been proven to promote bone healing in experimental settings and has been used clinically for many years and yet it has not become a mainstream clinical treatment. Methods To better understand this discrepancy we reviewed 72 animal and 69 clinical studies published between 1978 and 2017, and separately asked 161 orthopedic surgeons worldwide about their awareness, experience, and acceptance of EStim for treating fracture patients. Results Of the 72 animal studies, 77% reported positive outcomes, and the most common model, bone, fracture type, and method of administering EStim were dog, tibia, large bone defects, and DC, respectively. Of the 69 clinical studies, 73% reported positive outcomes, and the most common bone treated, fracture type, and method of administration were tibia, delayed/non-unions, and PEMF, respectively. Of the 161 survey respondents, most (73%) were aware of the positive outcomes reported in the literature, yet only 32% used EStim in their patients. The most common fracture they treated was delayed/non-unions, and the greatest problems with EStim were high costs and inconsistent results. Conclusion Despite their awareness of EStim’s pro-fracture healing effects few orthopedic surgeons use it in their patients. Our review of the literature and survey indicate that this is due to confusion in the literature due to the great variation in methods reported, and the inconsistent results associated with this treatment approach. In spite of this surgeons seem to be open to using this treatment if advancements in the technology were able to provide an easy to use, cost-effective method to deliver EStim in their fracture patients.
Content may be subject to copyright.
Vol.:(0123456789)
1 3
European Journal of Trauma and Emergency Surgery
https://doi.org/10.1007/s00068-019-01127-z
REVIEW ARTICLE
Electrical stimulation‑based bone fracture treatment, ifit works
sowell why donotmore surgeons use it?
MitBalvantrayBhavsar1 · ZhihuaHan1· ThomasDeCoster2· LiudmilaLeppik1· KarlaMychellyneCostaOliveira1·
JohnHBarker1
Received: 24 November 2018 / Accepted: 29 March 2019
© Springer-Verlag GmbH Germany, part of Springer Nature 2019
Abstract
Background Electrical stimulation (EStim) has been proven to promote bone healing in experimental settings and has been
used clinically for many years and yet it has not become a mainstream clinical treatment.
Methods To better understand this discrepancy we reviewed 72 animal and 69 clinical studies published between 1978 and
2017, and separately asked 161 orthopedic surgeons worldwide about their awareness, experience, and acceptance of EStim
for treating fracture patients.
Results Of the 72 animal studies, 77% reported positive outcomes, and the most common model, bone, fracture type, and
method of administering EStim were dog, tibia, large bone defects, and DC, respectively. Of the 69 clinical studies, 73%
reported positive outcomes, and the most common bone treated, fracture type, and method of administration were tibia,
delayed/non-unions, and PEMF, respectively. Of the 161 survey respondents, most (73%) were aware of the positive outcomes
reported in the literature, yet only 32% used EStim in their patients. The most common fracture they treated was delayed/
non-unions, and the greatest problems with EStim were high costs and inconsistent results.
Conclusion Despite their awareness of EStim’s pro-fracture healing effects few orthopedic surgeons use it in their patients.
Our review of the literature and survey indicate that this is due to confusion in the literature due to the great variation in
methods reported, and the inconsistent results associated with this treatment approach. In spite of this surgeons seem to be
open to using this treatment if advancements in the technology were able to provide an easy to use, cost-effective method to
deliver EStim in their fracture patients.
Keywords Bone fracture healing· Electrical stimulation treatment· Literature review· Survey of orthopedic surgeons
Introduction
The earliest report of using EStim to treat bone fractures
in patients appeared in the mid-1800s in which Garrat [1]
described using metallic needles placed in non-healing
fractures to deliver DC EStim, that resulted in successful
healing. Today, in the clinical setting EStim is administered
using three different approaches; direct current (DC), pulsed
electromagnetic field (PEMF), and capacitive coupled (CC).
DC EStim is administered via a surgically implanted EStim
power source and electrodes, and is administered at dos-
ages between 10 and 100μA of current [2]. CC and pulsed
PEMF are both administered externally. In CC an alternat-
ing voltage is applied to cutaneous electrodes placed on
opposite sides of the fracture generating an electrical field
of 0.1–20G [3]. In PEMF alternating currents, in current-
carrying coils, on the skin over the fracture site, generate a
pulsed electromagnetic field ranging between 3 and 10V
peak-to-peak within the fracture site [4].
In most cases EStim is used as a last resort after other
treatments have failed and/or in combination with other
treatments in cases of problematic fractures that heal
slowly (delayed union) or do not heal at all (non-union) [5].
Mit Balvantray Bhavsar and Zhihua Han contributed equally to the
work.
* John H Barker
JHB121654@gmail.com
1 Frankfurt Initiative forRegenerative Medicine,
Experimental Trauma andOrthopedic Surgery, J.W. Goethe-
University, Friedrichsheim gGmbH, Haus 97 B, 1OG,
Marienburgstraße. 2, 60528FrankfurtamMain, Germany
2 Department ofOrthopedics andRehabilitation, University
ofNew Mexico, Albuquerque, NM, USA
M.B.Bhavsar et al.
1 3
Examples include; spinal fusion [6], avascular necrosis [7],
internal and external fixation [8], delayed- or non-union frac-
tures [9], osteotomies [10], bone grafts [11], and femoral
osteonecrosis [12]. In these cases, EStim has been generally
reported to promote bone healing and help resolve these dif-
ficult, often chronic, costly, and debilitating fractures.
Several recently published invitro studies suggest that
EStim’s pro-healing effect is due to its influence on the
behavior and/or function of bone-forming stem cells. Along
these lines, we and others have shown that EStim causes bone
forming stem cells to migrate [13, 14], proliferate [15, 16],
differentiate [1720], increase mineralization [21], deposit
extracellular matrix [22], attach to scaffold materials [23],
and increase the expression of several osteogenic genes [19,
20]. Importantly, all these cell behaviors/functions play key
roles in fracture healing and/or bone regeneration. In addi-
tion to these invitro findings at the cellular level, in invivo
studies in rat forelimb amputation [24] and large bone defect
models [25] we have demonstrated that EStim significantly
stimulates new bone, cartilage, and vessel formation and
promotes healing and regeneration. In spite of these posi-
tive results in preclinical and clinical studies EStim has not
become a widespread, universally used clinical treatment.
To better understand this discrepancy between the
reported positive results and the relatively low use of EStim
in fracture treatment we reviewed the literature and we asked
orthopedic surgeons worldwide (in a survey) about their
awareness, experience, and acceptance of EStim treatment
in their fracture patients. Using this combined approach,
we hoped to better understand the discrepancy between the
demonstrated success of EStim fracture treatment, and its
relatively low use clinically.
Methods
Literature review
To identify articles describing the use of EStim in bone heal-
ing, both in animal and clinical studies, we searched MED-
LINE, Google Scholar, and Web of Science databases for
articles describing invitro and invivo animal studies and clini-
cal studies published between 1977 and 2017. To maximize
the sensitivity of the search and identify the greatest number
of studies, we used different combinations of the keywords
“electrical stimulation” and “bone healing” and reviewed the
reference lists of retrieved publications to identify additional
articles we may have missed searching the three databases. We
categorized the total number of articles identified into “animal
studies”, “clinical studies”, “cell/organ invitro”, and “reviews/
meta analyses” (Table1). Since the focus of our study was to
investigate EStim’s effect on fracture healing we reviewed only
articles that described fracture healing in animal and clinical
studies, and excluded publications focused on invitro stud-
ies, electrical properties of bone, connective tissue, electri-
cal stimulation of nerves and reviews or meta-analyses. The
animal studies we identified and reviewed are listed in Table2
categorized by animal model studied, bone and fracture type,
type of EStim treatment used, outcomes, and the listing of
the published article, alongwiththe number of occurrences
in each category. The clinical studies reviewed are listed in
Table3 under the subtitles; bone and fracture type, number of
cases, EStim treatment used, outcomes, complications, and the
published article citedalongwith the total numbers for each of
these categories. The total numberfor each of these categories
issummarized in Table3. The language of the publications
reviewed was English.
Orthopedic surgeon survey
To determine the level of awareness, experience, and accept-
ance of EStim-based bone fracture treatment we asked ortho-
pedic surgeons six questions (listed in Figs.1, 2, 3, 4, 5, 6)
using a closed online automated survey method (Survey-
Monkey software, Palo Alto, USA). Survey participants were
identified from our own network of colleagues and based on
their surgical specialty, “Orthopedic Surgeons” in the online
professional networking website, LinkedIn [26]. Between May
and August 2017, a total of 620 invitations were emailed to
orthopedic surgeons worldwide, and their IP addresses were
used to record their country of origin and to prevent dupli-
cate entries. No other personal information was collected or
stored from the respondents. With this online survey method
participants were allowed to review their responses prior to
submitting their completed survey. Incomplete surveys were
not included in this analysis.
Results
Literature review
Our initial literature searches identified a total of 432 arti-
cles, published between 1977 and 2017 that focused on the
use of EStim to promote bone growth, fracture healing, and
Table 1 Total publications identified using different combinations of
the keywords “electrical stimulation” and “bone healing”
Study type Number of
publications
Animal studies 72
Clinical studies 69
Cell/organ invitro 238
Review/meta-analysis 53
Total 432
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
Table 2 Publications between 1977 and 2017 describing animal studies that use EStim to treat bone fractures
Animal model Bone affected and/or fracture type Type of EStim treatment Outcome Published article
Rabbits Femur/osteotomy Type: PEMF
Settings: 220–260G
Improved healing Aydin and Bezer [46]
Tibia/osteotomy Type: PEMF Improved healing (69%) Barak etal. [47]
Tibia/fracture Type: PEMF
Settings: pulse width 85µs
Duration: 30min/day
No effect Buzza etal. [48]
Tibia/osteotomy Type: PEMF
Settings: time-varying field 1.5Hz
Duration: 1h/day
Improved healing Fredericks etal. [49]
Lumbar spine/fusion Type: DC
Settings: 20–60µA
Improved healing France etal. [50]
Lumbar spine/fusion Type: CC Improved healing Gilotra etal. [51]
Patella–tendon junction/fracture Type: CC
Settings: 15–25mA
Improved healing Hu etal. [52]
Mandible/defect Type: DC
Settings: 20µA
Duration: 4weeks continuous
Improved healing Kim etal. [53]
Femur/defect Type: PEMF
Settings: 0.8mT
Duration: 4h/day
Improved healing Matsumoto etal. [54]
Tibia/fracture Type: PEMF
Settings: 8mT; 50Hz
Duration: 0.5h/day
Improved healing Ottani etal. [55]
Tibia/fracture Type: DC
Settings: 20µA
Duration: 0.5h/day continuous
Improved healing Rubinacci etal. [56]
Mandible/defect Type: DC
Settings: 7µA
Duration: 1–2weeks continuous
No effect Shafer etal. [57]
Tibia diaphysis/fracture Type: PEMF
Settings: 1.8G; 1.5Hz
Improved healing Shimizu etal. [58]
Femur, tibia/fracture Type: PEMF
Settings: repetitive pulse-72Hz
Duration: 12h/day continuous
No effect Smith and Nagel [59]
Tibia/osteotomy Type: PEMF
Settings: asymmetric pulse 1.5Hz
Duration: 20days continuous
No effect Taylor etal. [60]
Knee/osteochondral lesion Type: PEMF
Settings: 1.5mT; 75Hz
Duration: 4h/day for 40days
Improved healing Veronesi etal. [61]
Humerus/fracture Type: PEMF
Settings: 2G, 25µs pulses at 10Hz
Duration: 12h/day × 14days
Improved healing Yonemori etal. [62]
Tibia/fracture Type: DC
Settings: 1, 5, 20µA
Improved healing Zimmermann etal. [63]
M.B.Bhavsar et al.
1 3
Table 2 (continued)
Animal model Bone affected and/or fracture type Type of EStim treatment Outcome Published article
Dogs Ulna/fracture Type: DC
Settings: 20µA
Duration: continuous
No effect Berry etal. [64]
Tibia/fracture Type: DC
Settings: 10–20µA
Duration: continuous
Improved healing (70–80%) Bins-Ely etal. [65]
Mandible/defect Type: DC
Settings: 20µA
No effect Branham etal. [66]
Radius/fracture Type: DC
Settings: 0.1–17µA
Improved healing Chakkalakal etal. [67]
Femur/fracture Type: DC
Settings: 50µA
Duration: 6weeks continuous
Improved healing Colella etal. [68]
Radius, ulna/fracture Type: DC
Settings: 20µA
Duration: 12weeks continuous
Improved healing Connolly etal. [69]
Lumbar spine/fusion Type: DC
Settings: 0.83–10µA
Duration: 6weeks continuous
Improved healing Dejardin etal. [70]
Femur/fracture Type: CC
Settings: biphasic waveforms
Improved healing Doyle [71]
Radius/fracture Type: DC
Settings: 3–5µA
Improved healing Fuentes etal. [72]
Tibia/fracture Type: PEMF
Settings: 0–2.4G
Duration: 4h/day
Improved healing Inoue etal. [73]
Periodontal/defect Type: DC
Settings: 3–6nA
Duration: continuous
No effect Jacobs and Norton [74]
Ulna/non-union Type: DC
Settings: 20µA
Improved healing (22%) Jacobs etal. [75]
Lumbar spine/fusion Type: PEMF
Settings: 1G; 1.5Hz
Duration: 0.5–1h/day
No effect Kahanovitz etal. [76]
Femur/fracture Type: DC
Settings: 20µA
No effect Lindsey etal. [77]
Cranium/osteogenesis Type: DC
Settings: 20µA
No effect Moderessi etal. [78]
Mandible/osteogenesis Type: PEMF
Duration: 1h/day
Improved healing Ortman etal. [79]
Mandible/non-union Type: DC Improved healing Park etal. [80]
Tibia/non-union Type: DC
Settings: 20µA
Improved healing Paterson etal. [81]
Tibia/non-union Type: DC
Settings: 20µA
Improved healing Paterson etal. [82]
Tibia/defect Type: DC
Settings: 0.2–20µA
Improved healing Paterson etal. [83]
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
Table 2 (continued)
Animal model Bone affected and/or fracture type Type of EStim treatment Outcome Published article
Tibia/fracture Type: CC
Settings: 3–6.3V; 60kHz
Duration: continuous—28days
No effect Pepper etal. [84]
Hip prostheses Type: CC
Settings: 5–6V; 60kHz
No effect Schutzer etal. [85]
Mandible/defect Type: DC
Settings: 20µA
Improved healing Shayesteh etal. [86]
Femur/osteotomy Type: DC
Settings: 1.5V
Improved healing Shokry [87]
Tibia, femur/fracture Type: DC
Settings: 0–50µA
Improved healing Srivastava [88]
Rats Femur/fracture Type: PEMF
Settings: 1.5mT
Duration: 6h/day
Improved healing Atalay etal. [89]
Tibia/osteoporosis Type: CC
Settings: low voltage; 60Hz
Improved healing Brighton etal. [90]
Tibia/fracture Type: CC
Duration: 20min/day
Improved healing Giannunzio etal. [91]
Spine/fusion Type: PEMF
Duration: 18h/day
Improved healing Guizzardi etal. [92]
Tibia/osteoporosis Type: PEMF
Settings: 1G; 5ms pulse; 15Hz
Duration: 2h/day
No effect Jagt etal. [93]
Tibia/osteoporosis Type: PEMF
Settings: 30mW/cm2; 1.5MHz
Improved healing Lirani-Galvao etal. [94]
Tibia/osteoporosis Type: CC
Settings: 10V peak–peak
Duration: 2h/day
Improved healing Manjhi etal. [95]
Fibula/osteotomy Type: CC
Settings: 1590V; 60Hz
Improved healing Marino etal. [96]
Spine/injury Type: CC
Settings: 30mW/cm2
Improved healing Medalha etal. [97]
Tibia/fracture Type: DC
Settings: 20µA
Duration: 20min/day
Improved healing Nakajima etal. [98]
Femur/fracture Type: PEMF
Settings: 41Gauss
Improved healing Puricelli etal. [99]
Tibia/osteoporosis Type: PEMF
Settings: 8G; 15Hz
Duration: 2h/day
Improved healing Shen and Zhao [100]
Spine/bone growth Type: DC
Settings: 0–100µA
Improved healing Spadaro [101]
Mandible/defect Type: PEMF
Settings: 1.5–1.8G; 100Hz
Improved healing Takano-Yamamoto etal. [102]
Periodontal/defect Type: DC
Settings: 0–100µA; 9kHz
Duration: once per day
Improved healing Tomofuji etal. [103]
M.B.Bhavsar et al.
1 3
Table 2 (continued)
Animal model Bone affected and/or fracture type Type of EStim treatment Outcome Published article
Mandible/fracture Type: DC
Settings: 9V
Duration: 24h
Improved healing Uysal etal. [104]
Cranium/defect Type: DC
Settings: 2mA; 2Hz
Duration: 15min; 3×weeks
Improved healing Yang etal. [105]
Spine/injury Type: DC (subcutaneous)
Settings: 15mA; 2Hz
Duration: 0.5h/day; 3weeks
Improved healing Yu etal. [106]
Spine/injury Type: DC (subcutaneous)
Settings: 20–150mA; 50Hz
Duration: 20min/day
Improved healing Zamarioli etal. [107]
Sheep Femur/defect Type: PEMF
Settings: 1.5mT; 75Hz
Duration: 6h/day
Improved healing Benazzo etal. [108]
Tibia/fracture Type: DC
Settings: 7.5µA
Duration: 12h/day
No effect Dergin etal. [109]
Spine/injury Type: DC
Settings: low voltage
Improved healing Flouty etal. [110]
Mandible/defect Type: DC
Settings: 10µA
Duration: 1mm/day×10days
Improved healing El-Hakim etal. [111]
Tibia/osteotomy Type: PEMF
Settings: 1.6mT
Duration: 24h/day
No effect Law etal. [112]
Tibia/fracture Type: CC
Settings: 15mA; 60kHz
Improved healing Mutthini etal. [113]
Lumbar spine/fusion Type: DC
Settings: 40–100µA
Improved healing Toth [ 114]
Horse Metacarpus/defect Type: PEMF
Settings: 28G; 75Hz
Improved healing Cane etal. [115]
Tibia/bone graft Type: PEMF
Settings: asymmetric pulse burst of 30ms duration
repeated at 1.5Hz
Improved healing Kold and Hickman [116]
Metatarsal-foot/osteotomy Type: PEMF
Settings: 20G; 15Hz
Duration: 8h/day
No effect Sanders-Shami etal. [117]
Total no.
of articles
Animal model (no.) Type of bone (no.) Type of fracture (no.) Type of EStim (%) Outcomes (%)
Dog Rat Rabbit Sheep Horse Tibia Femur Spine Mandible Other Delayed-/non-union Fusion Osteotomy Large bone defects Others PEMF DC CC Positive Negative
72 25 19 18 7 3 26 13 11 9 16 4 9 3 38 18 35 49 16 77 23
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
bone regeneration. Of these 432 publications, 72 reported
animal studies, 69 clinical studies, 238 organ or invitro
cell culture studies, and 53 were reviews or meta-analyses
(Table1). A total of 141 publications (animal + clinical stud-
ies) were selected and reviewed, the results of which are
presented herein.
Animal studies
A total of 72 animal study articles, that used EStim to treat
bone fractures were reviewed. The most commonly used
animal model was the dog (25), followed by rabbits (18),
rats (19), sheep (7) and horses (3). In these the “bone”, and
“fracture type” studied varied greatly. The bones were pri-
marily the tibia (26), femur (13), spine (11), mandible, (9)
and others (16). Some of the papers reviewed studied more
than one bone. The types of fractures/pathologies were large
bone defects (38), delayed- and non-unions (4), fusions (9),
osteotomies (3), and others (18). The most common method
used to administer electrical stimulation in the animal stud-
ies was DC EStim (49%), followed by PEMF (35%) and CC
and other types, together making up 16% of the reviewed
studies.
Clinical studies
A total of 69 articles describing clinical studies were
reviewed, in which EStim was used to promote bone healing.
The main bones treated with EStim in the clinical studies
were tibia (25), femur (15), spine (15), radius (11), humerus
(7) and others (20). As in the case with the animal study arti-
cles some of the clinical papers reported on more than one
bone. The most common types of fractures/pathologies were
delayed- and non-unions (21), spine fusions (16), arthro-
deses (5), osteotomies (4), necrosis (2), large bone defects
(2) and others (19). Most of the clinical studies reviewed
administered EStim using PEMF (60%), followed by DC
(29%), and CC and other methods (11%). The intensity of
the magnetic field used in PEMF treatment ranged between
0.3 and 6mT, while for DC the dosage was 5–40µA, and
for CC treatment the intensity ranged between 3 and 10V.
Half (50%) of the regimens used in the clinical studies con-
sisted of daily stimulation treatments ranging from 0.5 to
16h/day. Nineteen of the 69 studies (27%) reported com-
plications that included skin irritation and infections, pain
[27], dislocation of the device [28], failure of the device [29]
and poor patient compliance [30]. Fifty (72%) of the stud-
ies reviewed reported no complications. Finally, of the 69
clinical study publications 51 (73%) reported positive and
18 (27%) reported negative outcomes (Table3).
Orthopedic surgeon survey
The individual questions and the responses are displayed
in six separate graphs (Figs.1, 2, 3, 4, 5, 6). Of the 620
orthopedic surgeons who were sent emails inviting them
to participate in the survey, 161 (26%) from 34 countries
responded. Of the 161 respondents, 44% answered that they
perform more than 100, (23%) perform 51–100, (22%) per-
form 11–50, and (11%) perform 0–10 bone surgeries per
year (Fig.1). When asked if they were aware of published
clinical studies reporting successful EStim-based fracture
treatments, 85 (73%) responded “Yes” and the rest (27%)
answered “No” (Fig.2). Of the 85 respondents who said they
were aware of EStim-based fracture treatments, 27 (32%)
answered that they had used EStim in their fracture patients
while 58 (68%) had not (Fig.3). Of the 27 surgeons that
had used EStim in their patients the pathologies they treated
were mainly delayed or non-unions (61%) and large bone
defects (16%). The rest, (23%) were spinal fusion, avascu-
lar necrosis, calcaneal apophysitis, Charcot foot and ankle
reconstructions, loosened hip, knee prosthesis, or other types
of fractures (Fig.4). When asked what they considered to
be the major problems associated with using EStim in their
fracture patients, 30 (35%) identified “high cost”, 24 (28%)
answered “inconsistent results”, while 8% and 5% responded
that EStim devices were “impractical”, and “difficult” to use,
respectively. Eleven (13%) surgeons responded that they had
experienced “other” problems, and nine (11%) replied they
had not experienced problems using EStim-based treat-
ments (Fig.5). Finally, we asked, “If an easy-to-use EStim
device to treat bone fractures were available would you use
it in your patients?” and 85% answered, “Yes” and the rest
answered “No” (Fig.6).
Discussion
In his review of more than 100 studies using EStim treat-
ment, published more than 40years ago Spadaro concludes,
About 95% are positive reports…” and goes on to qualify
this assertion saying “…despite an extraordinarily wide
selection of experimental techniques and models” [31]. In
the present literature review of 141 papers (72 animal and
69 clinical studies), published in the 40years since then, we
also found positive results, and like Spadaro also found a
great variation in bone and fracture types, treatment meth-
ods, dosages, regimens, etc., reported in the literature. The
latter made it difficult to draw well-founded conclusions
upon which to develop specific EStim treatment recommen-
dations. One of the primary contributors to this confusion
in the literature is the different types, dosages, and regimens
used to administer EStim. In the clinical studies we reviewed
M.B.Bhavsar et al.
1 3
Table 3 Publications between 1977 and 2017 describing clinical studies that use EStim to treat bone fractures
Bone affected and/or
fracture type
No. of cases Type of EStim treatment Outcome Complications Published article
Mandible/fracture 12 Type: PEMF
Duration: 2h/day×12days
Settings: pulse duration 200ns, rise time
8ns, electromagnetic segment at 50MHz
and down to Hz range
No effect Infection Abdelrahim etal. [38]
Tibia/non-union 16 Type: CC
Duration: 7–8h/day until healed or 30weeks
Settings: 6V peak-to-peak symmetrical sine
wave signal at 63kHz frequency
Improved healing (68%) None reported Abeed etal. [118]
Tibia/acute fracture 106 Type: PEMF
Duration: 10h/day×12weeks
No effect None reported Adie etal. [119]
Lumbar spine/fusion 107 Type: DC Improved healing None reported Andersen etal. [6]
Lumbar spine/fusion 107 Type: DC No effect None reported Andersen etal. [120]
Lumbar spine/fusion 98 Type: DC
Settings: 40 and 100µA
No effect None reported Andersen etal. [121]
Tibia/delayed- and non-
union
44 Type: PEMF
Duration: 3h/day, maximum 36weeks
Improved healing (77%) None reported Assiotis etal. [122]
Tibia/non-union 9 Type: PEMF
Duration: 12–16h/day, min 1h/
day×48weeks
Settings: 1–5mT peak, 5ms burst waveform
repeated at 15Hz
No effect One patient left the study prior
to end
Barker etal. [32]
Femur/arthrodesis failure 71 Type: PEMF Improved healing (85%) None reported Bassett etal. [123]
Tibia/fracture 22 Type: CC
Duration: 15h/day until healed
Settings: sinusoidal wave 3–6V at 60kHz
and 5–10mA
No effect None reported Beck etal. [124]
Metatarsal foot/fracture 25 Type: CC
Duration: 52days
Setting: amplitude of 3.0–6.3V and 60kHz
frequency
Effective current—5–10mA
Improved healing (88%) None reported Benazzo etal. [125]
Femur/intertrochanteric
osteotomy
31 Type: PEMF
Duration: 8h/day×3m
Settings: 75Hz, 1.3ms impulse width,
2.5mV amplitude, and 18Gs magnetic
field amplitude
Improved healing None reported Borsalino etal. [10]
Radius/delayed-and non-
union and osteotomy
21 Type: PEMF
Duration: 10h/day
Improved (57% non-union healed)
Improved (89% osteotomies
healed)
None reported Boyette and Herrera-Soto
[126]
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
Table 3 (continued)
Bone affected and/or
fracture type
No. of cases Type of EStim treatment Outcome Complications Published article
Tibia/non-union 57 Type: DC
Settings: 10–20µA
Improved healing (70% healed) Eight patients did not receive
adequate electricity—due to
device failure
Brighton [29]
Tibia/non-union 20 Type: CC
Settings: 60kHz, 5V peak-to-peak
No effect 11 patients started with DC with-
drew prior to end of study
Brighton and Pollack [33]
Tibia/non-union 271 Type: DC and CC No effect Risk factors Brighton etal. [9]
Sesamoid-foot/delayed
union
1 Type: PEMF
Duration: 7–8h/day×52weeks
Improved healing None reported Bronner etal. [127]
Femur, Tibia, radius,
humerus/arthrodesis
24 Type: PEMF
Duration: 8h/day
Settings: 75Hz, 3.0 ± 0.5mV
No effect None reported Capanna etal. [128]
Tibia/pseudoarthroses 22 Type: PEMF
Duration: 8h/day, average 5–6ms
Settings: 75Hz, 10–20A/cm, 180–220V
Improved healing (90%) Infection (three cases), protrusion
of material (nine cases),
Screw break (three cases)
Cebrián etal. [37]
Tibia/fracture 33 Type: PEMF
Duration: 12–15/day, until healed
Settings: 0.8mT, 50Hz
Improved healing (85%) Infection Colson etal. [39]
Tibia/fracture 37 Type: DC Improved healing (100%) None reported Cundy and Paterson [81]
Tibia/non-union 17 Type: PEMF
Duration: 20h/day, 4–8weeks
Settings: 150–300Gs
No effect None reported De Haas etal. [129]
Hind foot/fusion 13 Type: DC Improved healing (92%) None reported Donley and Ward [130]
Humerus, tibia, femur/
non-union and oste-
otomy
52 Type: PEMF
Duration: 2–12m
Improved healing (82%) None reported Dunn and Rush [131]
Cervical spine/fusion 122 Type: PEMF
Duration: 4h/day×3m
Improved healing (83%) None reported Foley etal. [132]
Tibia/fracture 41 Type: DC interferential currents No effect Sepsis (six cases) Fourie and Bowerbank [133]
Tibia, hip, radius/delayed-
and non-union
12 Type: PEMF
Duration: 12h/day×3mmin
No effect None reported Freedman [134]
Knee/osteoarthritis 139 Type: CC
Duration: 6–14h/day
Improved healing None reported Garland etal. [135]
Lumbar spine/fusion 85 Type: CC
Duration: 24h/day until healed or 9m
Setting: 60kHz, current density 5µA root
mean square/cm2, 12mV root mean
square/cm
Improved healing (84%) None reported Goodwin etal. [136]
Tibia/non-union 45 Type: PEMF
Duration: 12h/day, 6–12weeks
Settings: 0.008Weber/m2
Improved healing (35% healed in
10weeks and 85% in 4ms)
Poor compliance Gupta etal. [30]
M.B.Bhavsar et al.
1 3
Table 3 (continued)
Bone affected and/or
fracture type
No. of cases Type of EStim treatment Outcome Complications Published article
Foot joint/arthropathy 11 Type: PEMF (combined)
Duration: 0.5h/day
Improved healing None reported Hanft etal. [137]
Hand/acute fracture 53 Type: PEMF
Duration: continuous for 52weeks
Settings: pulse amplitude 50mV
Pulse width 5μs; burst width 5ms
Burst refractory period 62ms
Repeat repetition rate 15Hz
No effect None reported Hannemann etal. [138]
Hand/acute fracture 102 Type: PEMF
Duration: continuous max 52weeks
Settings: pulse amplitude 50mV
Pulse width 5μs; burst width 5ms
Burst refractory period 62ms
Repeat repetition rate 15Hz
No effect None reported Hannemann etal. [139]
Metatarsal-foot/delayed-
and non-union
9 Type: PEMF
Duration: 8–10h/day×3m
Settings: 0–20Gs, 4.5ms pulse bursts dura-
tion repeated at 15Hz
Improved healing (100%) None reported Holmes [140]
Tibia/non-union 30 Type: PEMF
Duration: 8h/day
Settings: 1–15mV, 5ms bursts of asym-
metrical 15Hz pulses
Improved healing (83%) None reported Ito and Shirai [141]
Radius/fracture 18 Type: DC (pulsed)
Settings: 2Hz, 30µA
Improved healing None reported Itoh etal. [142]
Lumbar spine/fusion 17 Type: DC and PEMF No effect Infection Jenis etal. [143]
Tibia/fracture 24 Type: pulsed DC
Duration: 6m
Settings: 1Hz, 40µA
Improved healing (30%) Skin reaction and infection Jorgensen [144]
Tibia/fracture 3 Type: DC
Duration: 30–60min 3–4×day
Settings: pulse width 300µs,
1–2Hz < 20mA
Improved healing (66%) None reported Kahn [145]
Lumbar spine/fusion 31 Type: DC Improved healing (78%) None reported Kane [146]
Spine/fusion 65 Type: DC Improved healing (96%) None reported Kucharzyk [147]
Radius/colles’ fracture 30 Type: PEMF
Duration: 30m/day, 5days/week×2weeks
Settings: 6mT, 25Hz
Improved healing None reported Lazovic [148]
Lumbar spine/fusion 104 Type: PEMF (combined)
Duration: 30m/day×9m
Improved healing (64%) None reported Linovitz [149]
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
Table 3 (continued)
Bone affected and/or
fracture type
No. of cases Type of EStim treatment Outcome Complications Published article
Humerus neck/fracture 21 Type: PEMF
Duration: 30m/day×10days
Settings: 35Hz, max pulse 300W
No effect None reported Livesley [150]
Radius/non-union 10 Type: PEMF
Duration: 104days
Settings: 2.5Gs
Improved healing (66%) None reported Madronero etal. [151]
Tibia/osteotomy 18 Type: PEMF
Duration: 8h/day×57days
Settings: pulse duration 1.3ms, 75Hz,
3.0 ± 0.5mV
Improved healing Thrombophlebitis (three cases) Mammi etal. [152]
Lumbar spine/fusion 42 Type: PEMF
Duration: 4h/day
Improved healing (97%) None reported Marks [153]
Femur/fracture 32 Type: PEMF
Duration: 1h/day×8weeks
Settings: 5–105Hz, 0.5–2.0mT
Improved healing (94%) None reported Martinez-Rondanelli etal.
[154]
Femur head/osteonecrosis 66 Type: PEMF
Duration: 8h/day×3–7m
Settings: 75Hz, 1.3ms pulse, 2 ± 0.5mV
Improved healing (94%) None reported Massari etal. [155]
Mandible/fracture 40 Type: DC
Duration: 10–14days
Settings: 10–20µA
Improved healing None reported Masureik and Eriksson [156]
Lumbar spine/fusion 122 Type: DC
Duration: 24weeks min
Settings: 20µA
Improved healing (76%) Infection (four cases) Meril [40]
Tibia/delayed- and non-
union
57 Type: PEMF Improved healing (75%) None reported Meskens [157]
Tibia/congenital pseudar-
throsis
27 Type: DC
Duration: 6m
Settings: 20µA
Improved healing (74%) Infection (two cases) Paterson and Simonis [158]
Humerus, ulna, radius,
femur, tibia/non-union
93 Type: PEMF
Duration: 13weeks
Settings: pulse amplitude 50mV
Pulse width 5s at 15Hz
Improved healing (74%) None reported Punt etal. [159]
Ankle/cystic osteochon-
dral defect
68 Type: PEMF
Duration: 4h/day×60days
Settings: 1.5mT at 75Hz
No effect Temporary foot paresthesia×2
Wound drainage×2
Reilingh etal. [160]
Lumbosacral spine/fusion 53 Type: DC
Duration: 20.5m
Settings: 10µA/cathode
Improved healing (96%) None reported Rogozinski and Rogozinski
[161]
Foot, ankle arthrodesis/
delayed union
19 Type: PEMF
Duration: 5–27m
Improved healing (77%) None reported Saltzman etal. [162]
M.B.Bhavsar et al.
1 3
Table 3 (continued)
Bone affected and/or
fracture type
No. of cases Type of EStim treatment Outcome Complications Published article
Tibia, femur/non-union 10 Type: CC
Duration: 6m
Setting: 5–10V peak-to-peak sine, 60kHz
Improved healing (60%) Electrode allergic skin reaction
(two cases)
Scott and King [163]
Tibia/delayed union 20 Type: PEMF
Duration: 12h/day×12weeks
Settings: 200µs with 25µs interval, 5T/s
Improved healing None reported Sharrad [28]
Humerus, ulna, radius,
femur, tibia/non-union
53 Type: PEMF
Duration: 12–16h/day×3m
Settings: 5ms bursts, 15Hz, 11.5mV
Improved healing (71%) Plate/screw loosening (eight
cases)
Sharrad etal. [8]
Humerus, ulna, radius,
femur, tibia/non-union
31 Type: PEMF
Duration: 8h/day×5m
Improved healing (77%) None reported Shi etal. [164]
Lumbar spine/fusion 13 Type: PEMF
Duration: 8–10h/day×4m
Settings: 0–0.0003T, 50ms pulse repetition
rate
Improved healing (76%) None reported Simmons [165]
Lumbar spine/fusion 100 Type: PEMF
Duration: 2h/day×90daymin
Improved healing (67%) None reported Simmons etal. [166]
Metatarsal-foot/non-union 5 Type: PEMF
Duration: 10h/day×24weeks max
Improved healing None reported Streit etal. [167]
Femur head/avascular
necrosis
20 Type: CC
Duration: 24h/day×6m
No effect None reported Steinberg etal. [168]
Lumbar spine/fusion 143 Type: DC
Duration: 24weeks
Settings: 20µA
Improved healing (91.5%) Pain Tejano etal. [27]
Ankle/cystic osteochon-
dral defect
68 Type: PEMF
Duration: 4h/day×60days
Settings: 1.5mT at 75Hz
Improved healing None reported van Bergen etal. [169]
Radius/fracture 15 Type: PEMF
Duration: 8weeks
Settings: 0.00004T at 1–1000Hz
Improved healing None reported Wahlstrom and Knutsson
[170]
Cervical spine/arthrodesis 16 Type: DC
Duration: 26weeks min; settings: 12µA
Improved healing (93%) Infection (one case)
Local discomfort (four cases)
Welch etal. [171]
Total no. of
articles
Type of bone (no.) Type of fracture (no.) Type of EStim
(%)
Compli-
cations
(%)
Outcomes (%)
Tibia Femur Spine Radius Humerus Others Delayed-/
non-union
Fusion Arthrode-
sis
Osteotomy Necrosis Bone
defect
Others PEMF DC CC Yes No Positive Negative
69 25 15 15 11 7 20 21 16 5 4 2 2 19 60 29 11 27 73 73 27
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
Fig. 1 How many bone surgeries do you perform per year?
Fig. 2 Did you know that electrical stimulation has been proven to
accelerate bone healing in many clinical studies?
Fig. 3 Have you ever used an electrical stimulation device to treat
bone fractures in your patients?
Fig. 4 In what type of bone fractures have you used an electrical
stimulation device?
Fig. 5 What problem(s) do you see in current devices?
Fig. 6 If an easy-to-use electrical stimulation device to treat bone
fractures were available, would you use it in your patients?
M.B.Bhavsar et al.
1 3
that the most commonly used method of administering
EStim was PEMF while in the animal studies DC was the
predominant treatment method. This preference in patients
is most likely due to the fact that PEMF is administered
using an external noninvasive device, whereas DC treat-
ment requires that the EStim device be surgically implanted.
While being noninvasive is a major benefit of PEMF for
clinical use, patient non-compliance, associated with its use,
is a major problem and is cited as one of the primary reasons
for inconsistent results when using PEMF [2830].
Another source of confusion is the dosages and regimens
used. The most commonly used dosage for administering
PEMF ranged between 0.3 and 6mT, while for DC the inten-
sity was 5–40µA, and for CC treatment the intensity ranged
between 3 and 10V. Half of the regimens used in the clinical
studies consisted of daily EStim treatments ranging from 0.5
to 16h/day, delivered either continuously or in interrupted
intervals, the latter being for periods of 1–6h/day. The dos-
ages, regimens, and exposure times in the animal studies
also varied widely. This great variation makes it difficult to
combine the results of these studies into one or a few treat-
ment recommendations. Another reason why it is difficult
to combine the results of the different studies is because
of the many different bones and fracture types studied. Of
all the different bones and fracture types reported in the
clinical articles by far the most common bone was the tibia
and the most studied fracture types were delayed- and non-
unions. In fact, this was confirmed in our survey in which
orthopedic surgeons that use EStim mostly used it to treat
delayed- and non-unions in their patients (Fig.4). Again,
this variation in bone and fracture types described in the
literature would make it difficult to compare healing rates
between, say a mandible and a tibia, or between non-unions
and osteotomies, which makes it difficult to draw meaning-
ful conclusions.
Poor fracture healing is often associated with both a lack
of healing and mal-position of bone fragments. In these
cases, surgeons prefer operative intervention to EStim
because of the ability to restore alignment as well as facili-
tate fracture healing. Revision fixation and osteotomies, to
correct alignment, are fraught with high rates of delayed
bone healing and persistent non-unions. While EStim does
not improve the position of bone fragments, it still can play
an adjunctive role in the treatment of non-unions [34].
When EStim is used as an adjunct to other treatment
attempts, as a last resort it can require prolonged and costly
interventions. While the clinical studies we reviewed did
not provide information about costs associated with EStim
treatments, information available online from companies
who sell clinical EStim devices indicate that the current
unit cost of most EStim devices, regardless of the company
(OL1000 Bone Growth Stimulator, Orthopak, EBI Bone
Healing System, Physio-Stim Lite, or Exogen), is about US
$3000. Additional coststo treat delayed unions is approxi-
mately$24,892, that includes $20,575 for surgery and recov-
ery + $4317 outpatient costs. These figures are quoted from
a report published by EXOGEN [35].
Added to this, failure rates in these treatments is relatively
high (17–64%) and when present can lead to additional costs
[36]. Finally, the costs associated with using EStim devices
are usually not reimbursed, thus further reducing the incen-
tive to use this treatment option. While comparing the costs
of EStim to other treatments used in problematic fractures
is beyond the scope of this paper, from the responses we
received in our survey it is clear that high costs is an impor-
tant factor for surgeons in their decision whether or not to
use EStim. Of the drawbacks associated with using EStim,
the greatest number of surgeons surveyed cited high costs as
being the main problem with using EStim in their fracture
patients (Fig.5).
The second most cited problem with EStim was incon-
sistent results. While the questions in our survey did not ask
about the specific cause of the inconsistent results associated
with using EStim, from our literature review we were able
to identify some possible causes. In the clinical papers a
few different device-related problems were cited that could
cause “inconsistent results”. These included “damaged”
or “disconnected” implanted stimulators, misplacement of
hardware, and migration of the EStim device’s electrode
leads that can occur due to muscle movement or insufficient
flexibility of the muscles [9, 28, 37]. Eight and five percent-
age of surgeons surveyed indicated that the problems they
encounter using EStim were associated to the devices used
to administer the treatment, choosing “impractical”, and
“difficult to use”, respectively, to describe their experience.
In a white paper generated by industry that compares costs
associated with the use of five different EStim bone stimula-
tors the authors write that using these devices the “probabil-
ity of failure” ranges between 17 and 64% [36]. While the
exact causes of failure are not specified in this paper these
high failure rates could certainly cause inconsistent results.
Of the 69 clinical studies we reviewed, 19 reported com-
plications experienced during treatment with EStim. In
these 19 studies, the most common type of complication
experienced was skin irritation and infections, when using
the externally applied PEMF device, and infections at the
fracture line when using the implanted DC device [2427].
Other types of complications experienced with EStim treat-
ment were pain [27], dislocation of the device [28], failure
of the device [29] and poor patient compliance [30]. The
above-mentioned complications and particularly patient non-
compliance could be other causes of the inconsistent results
surgeons cited in our survey. Existing external PEMF units
are cumbersome and require manyhours of treatment per
day over months, which interferes with activities of daily
living, causing decrease compliance. If a patient does not (or
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
is not able to) utilize the PEMF EStim device in the manner
prescribed then the beneficial effects are diminished. Smaller
units are available and only require 30-min treatments,
however, they require very precise fitting to encompass the
fracture site within the small field which also decreases the
effectively applied dose and clinical efficacy. Although 73%
of clinical studies demonstrate a benefit to EStim, the mag-
nitude and consistency of the effect are less than reported in
animal studies. Patient compliance is much lower in clinical
studies thanin animal studies. We believe that problems with
compliance account for the large gap in the results reported
in the clinical versus animal studies.
In a study we reviewed, Simmons etal. compared PEMF
(where patient compliance is required) to DC EStim (where
compliance is not an issue since the device is implanted),
and found that spinal fusion rates in the former were lower
than in the latter [41], attributing this difference to patient
non-compliance. In another study non-compliance was cited
as a possible reason for EStim-treated patients having the
same spinal fusion rates as non-treated controls [42]. The
above problems, “high cost”, “inconsistent results”, and
“impractical/difficult to use” go a long way toward answer-
ing our original question, why EStim-based fracture treat-
ments have not gained more acceptance in the orthopedic
community.
When comparing EStim to other adjunct treatments
used to treat delayed healing or non-unions, Ebrahim etal.
compared EStim with low intensity-pulsed ultrasound and
found no significant difference [43]. Kertzman etal. used
radial extracorporeal shock wave therapy to treat fracture
non-unions of superficial bones and found that 70% of tibia
non-unions healed within 6months suggesting that this
approach is on par with EStim [44]. Similarly, in a recent
study by Putnam etal. non-unions in 26 patients using surgi-
cal volar plate fixation and cancellous grafting, they found
82% healed by 12weeks [45]. With this, one can reasonably
assume that rates of success with these different procedures
are similar to those reported with EStim.
The present study had several drawbacks, the greatest
being difficulty making sense of the large variation in the
methods reported in the different studies we reviewed. In
both the animal and clinical studies, the bones and frac-
ture types studied, the EStim method/dosages/regimens,
and the methods used to report outcomes differed greatly.
This made it difficult to combine these various parameters
into well-founded treatment recommendations. Another
weakness in this study was positive publication bias. All
the articles we reviewed were published, and since stud-
ies that found EStim to be effective are more likely to be
written up, submitted, and accepted for publication, our
review did not include unpublished studies with negative
results. Another shortfall is related to the questions we
used in our survey. We did not test these questions for
validity or reproducibility prior to sending them out. Had
this been done perhaps we could have improved the quality
of the answers we received. Finally, in the survey we could
have included more specific questions that might have pro-
vided answers to other important questions such as the
specific causes of the problem’s respondents encountered
with EStim treatment. While it would have been nice to
get more information with more detailed questions, we
decided to have few and simple questions thinking that this
would help maximize the response rate in this first study.
Conclusion
Most of the orthopedic surgeons we surveyed were aware
of EStim and its positive outcomes in fracture treatment.
These positive outcomes were confirmed in the litera-
ture we reviewed, in which both preclinical animal and
clinical studies reported positive overall outcomes using
EStim to treat bone fractures. Despite the awareness and
positive impression our respondents had about EStim only
a fraction actually useit in their fracture patients. The
reason for this discrepancy could be problems such as,
confusion in the literature, due to the great variation in
methods reported, and the inconsistent results associated
with this treatment approach. On the positive side, when
asked “If an easy-to-use electrical stimulation device to
treat bone fractures were available, would you use it in
your patients?”, 85% of the surgeons surveyed responded
“Yes”. This suggests that despite the problems, given an
easy-to-use method for administering EStim, surgeons
are open to using this treatment approach. An improved
delivery system for EStim could overcome the compliance
problem, markedly increase the clinical efficacy and make
EStim an accepted form of treatment of non-unions and
acute fractures associated with poor healing.
Funding This study was supported in part by the Friedrichsheim Foun-
dation (Stiftung Friedrichsheim) based in Frankfurt/Main, Germany,
and the Chinese Scholarship Council (CSC).
Compliance with ethical standards
Conflict of interest The authors have no conflicts of interest to declare.
References
1. Garrat AC. Electrophysiology and electrotherapeutics. Boston:
Ticknor and Fields; 1860.
2. Kuzyk PR, Schemitsch EH. The science of electrical stimulation
therapy for fracture healing. Indian J Orthop. 2009;43(2):127–31.
https ://doi.org/10.4103/0019-5413.50846 .
M.B.Bhavsar et al.
1 3
3. Chalidis B, Sachinis N, Assiotis A, Maccauro G, Graziani F.
Stimulation of bone formation and fracture healing with pulsed
electromagnetic fields: biologic responses and clinical implica-
tions. Int J Immunopathol Pharmacol. 2011;24:17–20.
4. Aaron RK, Boyan BD, Ciombor DM, Schwartz Z, Simon BJ.
Stimulation of growth factor synthesis by electric and electro-
magnetic fields [review]. Clin Orthop. 2004;419:30–7.
5. Simonis RB, Parnell EJ, Ray PS, Peacock JL. Electrical treatment
of tibial non-union: a prospective, randomised, double-blind trial.
Injury. 2003;34:357–62.
6. Andersen T, Christensen FB, Ernst C, Fruensgaard S, Øster-
gaard J, Andersen JL, etal. The effect of electrical stimulation
on lumbar spinal fusion in older patients: a randomized, con-
trolled, multi-center trial: part 1: functional outcome. Spine.
2009;34:2241–7.
7. Steinberg ME, Brighton CT, Hayken GD, Tooze SE, Steinberg
DR. Early results in the treatment of avascular necrosis of the
femoral head with electrical stimulation. Orthop Clin N Am.
1984;15:163–75.
8. Sharrard WJ, Sutcliffe ML, Robson MJ, Maceachern AG. The
treatment of fibrous non-union of fractures by pulsing electro-
magnetic stimulation. J Bone Jt Surg Br. 1982;64:189–93.
9. Brighton C, Shaman P, Heppenstall R. Tibial nonunion treated
with direct current, capacitive coupling, or bone graft. Clin
Orthop. 1995;321:223–34.
10. Borsalino G, Bagnacani M, Bettati E, etal. Electrical stimulation
of human femoral intertrochanteric osteotomies. Clin Orthop.
1988;237:256–63.
11. Bassett CA, Mitchell SN, Schink MM. Treatment of therapeuti-
cally resistant non-unions with bone grafts and pulsing electro-
magnetic fields. J Bone Jt Surg Am. 1982;64:1214–20.
12. Steinberg ME, Brighton CT, Corces A, Hayken GD, Steinberg
DR, Strafford B, etal. Osteonecrosis of the femoral head. Results
of core decompression and grafting with and without electrical
stimulation. Clin Orthop Relat Res. 1989;249:199–208.
13. Tai G, Tai M, Zhao M. Electrically stimulated cell migration
and its contribution to wound healing. Burns Trauma. 2018;6:20.
https ://doi.org/10.1186/s4103 8-018-0123-2.
14. Yuan X, Arkonac DE, Chao PG, Vunjak-Novakovic G. Electrical
stimulation enhances cell migration and integrative repair in the
meniscus. Sci Rep. 2014;4:3674. https ://doi.org/10.1038/srep0 3674.
15. Ercan B, Webster TJ. Greater osteoblast proliferation on anodized
nanotubular titanium upon electrical stimulation. Int J Nanomed.
2008;3(4):477–85.
16. Guo BS, Cheung KK, Yeung SS, Zhang BT, Yeung EW. Electri-
cal stimulation influences satellite cell proliferation and apop-
tosis in unloading-induced muscle atrophy in mice. PLoS One.
2012;7(1):e30348. https ://doi.org/10.1371/journ al.pone.00303 48.
17. Serena E, Figallo E, Tandon N, Cannizzaro C, Gerecht S, Elvas-
sore N, etal. Electrical stimulation of human embryonic stem
cells: cardiac differentiation and the generation of reactive oxy-
gen species. Exp Cell Res. 2009;315(20):3611–9. https ://doi.
org/10.1016/j.yexcr .2009.08.015.
18. Yamada A, Gaja N, Ohya S, Muraki K, Narita H, Ohwada
T, etal. Usefulness and limitation of DiBAC4(3), a voltage-
sensitive fluorescent dye, for the measurement of membrane
potentials regulated by recombinant large conductance
Ca2+-activated K+ channels in HEK293 cells. Jpn J Pharmacol.
2001;86(3):342–50.
19. Eischen-Loges M, Oliveira KMC, Bhavsar MB, Barker JH, Lep-
pik L. Pretreating mesenchymal stem cells with electrical stimu-
lation causes sustained long-lasting pro-osteogenic effects. PeerJ.
2018;6:e4959. https ://doi.org/10.7717/peerj .4959.
20. Mobini S, Leppik L, Parameswaran VT, Barker JH. Invitro effect
of direct current electrical stimulation on rat mesenchymal stem
cells. PeerJ. 2017;12(5):e2821. https ://doi.org/10.7717/peerj
.2821.
21. Behari J. Effect of electrical stimulation in mineralization and
collagen enrichment of osteoporotic rat bones. In: 2008 Interna-
tional conference on recent advances in microwave theory and
applications 2008.
22. Durigan JLQ, Peviani SM, Delfino GB, De Souza Jose RJ, Parra
T, Salvini TF. Neuromuscular electrical stimulation induces
beneficial adaptations in the extracellular matrix of quadriceps
muscle after anterior cruciate ligament transection of rats. Am J
Phys Med Rehabil. 2014;93(11):948–61. https ://doi.org/10.1097/
PHM.00000 00000 00011 0.
23. George PM, Bliss TM, Hua T, Lee A, Oh B, Levinson A,
etal. Electrical preconditioning of stem cells with a conduc-
tive polymer scaffold enhances stroke recovery. Biomaterials.
2017;142:31–40. https ://doi.org/10.1016/j.bioma teria ls.
24. Leppik LP, Froemel D, Slavici A, Ovadia ZN, Hudak L, Henrich
D, etal. Effects of electrical stimulation on rat limb regeneration,
a new look at an old model. Sci Rep. 2015;17(5):18353. https ://
doi.org/10.1038/srep1 8353.
25. Leppik L, Zhihua H, Mobini S, Parameswaran VT, Eischen-Loges
M, Slavici A, etal. Combining electrical stimulation and tissue
engineering to treat large bone defects in a rat model. Sci Rep.
2018;8(1):6307. https ://doi.org/10.1038/s4159 8-018-24892 -0.
26. Brochet F, Weber J. LinkedIn Corporation. Harvard Business
School Case 112–006; 2012.
27. Tejano N, Puno R, Ignacio JM. The use of implantable direct cur-
rent stimulation in multilevel spinal fusion without instrumenta-
tion. Spine. 1996;21(16):1904–8. https ://doi.org/10.1097/00007
632-19960 8150-00015 .
28. Sharrard WJW. A double-blind trial of pulsed electromagnetic
fields for delayed union of tibial fractures. J Bone Jt Surg Br.
1990;72:347–55.
29. Brighton CT. Treatment of non-union of the tibia with constant
direct current. J Trauma. 1981;21:189–95.
30. Gupta AK, Srivastava KP, Avasthi S. Pulsed electromagnetic
stimulation in nonunion of tibial diaphyseal fractures. Indian
J Orthop. 2009;43(2):156–60. https ://doi.org/10.4103/0019-
5413.50850 .
31. Spadaro JA. Electrically stimulated bone growth in animals
and man. Review of the literature. Clin Orthop Relat Res.
1977;122:325–32.
32. Barker AT, Dixon RA, Sharrard WJW, Sutcliffe ML. Pulsed
magnetic field therapy for tibial non-union. Interim results of a
double-blind trial. Lancet. 1984;1:994–6.
33. Brighton C, Pollack S. Treatment of recalcitrant non-unions
with a capacitively coupled electrical field. J Bone Joint Surg.
1985;67A:577–85.
34. Kooistra BW, Jain A, Hanson BP. Electrical stimulation: nonun-
ions. Indian J Orthop. 2009;43(2):149–55.
35. EXOGEN. EXOGEN® Bone healing system shown to be most
cost-effective bone stimulator. 2005.
36. Schultz M, Oremus M, Whitman C, Conway J. Cost-effectiveness
of bone stimulators in the conservative treatment of stable nonun-
ion fractures. Value Health. 2004;7:723 (International Society
for Pharmacoeconomics and Outcomes Research (ISPOR)).
37. Cebrián JL, Gallego P, Francés A, Sánchez P, Manrique E, Marco
F, etal. Comparative study of the use of electromagnetic fields in
patients with pseudoarthrosis of tibia treated by intramedullary
nailing. Int Orthop. 2010;34(3):437–40. https ://doi.org/10.1007/
s0026 4-009-0806-1.
38. Abdelrahim A, Hassanein HR, Dahaba M. Effect of pulsed elec-
tromagnetic field on healing of mandibular fracture: a prelimi-
nary clinical study. J Oral Maxillofac Surg. 2011;69(6):1708–17.
https ://doi.org/10.1016/j.joms.2010.10.013.
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
39. Colson DJ, Browett JP, Fiddian NJ, Watson B. Treatment of
delayed- and non-union of fractures using pulsed electromagnetic
fields. J Biomed Eng. 1988;10:301–4.
40. Meril AJ. Direct current stimulation of allograft in anterior and
posterior lumbar interbody fusions. Spine. 1994;19:2393–8.
41. Simmons JW, Hayes MA, Christensen DK, Dwyer AP, Koullsis
CS, Kimmich SJ. The effect of postoperative pulsing electromag-
netic fields on lumbar fusion: an open trial phase study. Quebec,
Canada: Presented at the North American Spine Society; 1989.
42. Lee K. Clinical investigation of the spinal stem system open trial
phase: pseudarthrosis stratum. Las Vegas, Nevada: Presented at
the annual meeting of the American Academy of Orthopaedic
Surgeons; 1989.
43. Ebrahim S, Mollon B, Bance S, Busse JW, Bhandari M. Low-
intensity pulsed ultrasonography versus electrical stimulation for
fracture healing: a systematic review and network meta-analysis.
Can J Surg. 2014;57(3):E105–18.
44. Kertzman P, Császár NBM, Furia JP, Schmitz C. Radial extra-
corporeal shock wave therapy is efficient and safe in the treat-
ment of fracture nonunions of superficial bones: a retrospective
case series. J Orthop Surg Res. 2017;12(1):164. https ://doi.
org/10.1186/s1301 8-017-0667-z.
45. Putnam JG, Mitchell SM, DiGiovanni RM, Stockwell EL,
Edwards SG. Outcomes of unstable scaphoid nonunion with
segmental defect treated with plate fixation and autogenous can-
cellous graft. J Hand Surg Am. 2019;44(2):160.e1–7. https ://doi.
org/10.1016/j.jhsa.2018.05.023.
46. Aydin N, Bezer M. The effect of an intramedullary implant with
a static magnetic field on the healing of the osteotomised rabbit
femur. Int Orthop. 2011;35(1):135–41. https ://doi.org/10.1007/
s0026 4-009-0932-9.
47. Barak S, Neuman M, Iezzi G, Piattelli A, Perrotti V, Gabet Y. A
new device for improving dental implants anchorage: a histologi-
cal and micro-computed tomography study in the rabbit. Clin
Oral Implant Res. 2016;27(8):935–42. https ://doi.org/10.1111/
clr.12661 .
48. Buzza EP, Shibli JA, Barbeiro RH, Barbosa JR. Effects of elec-
tromagnetic field on bone healing around commercially pure tita-
nium surface: histologic and mechanical study in rabbits. Implant
Dent. 2003;12:182–7.
49. Fredericks DC, Piehl DJ, Baker JT, Abbott J, Nepola JV. Effects
of pulsed electromagnetic field stimulation on distraction osteo-
genesis in the rabbit tibial leg lengthening model. J Pediatr
Orthop. 2003;23:478–83.
50. France JC, Norman TL, Santrock RD, McGrath B, Simon BJ. The
efficacy of direct current stimulation for lumbar intertransverse
process fusions in an animal model. Spine. 2001;26:1002–8.
51. Gilotra M, Griffith C, Schiavone J, Nimmagadda N, Noveau
J, Ludwig SC. Capacitive coupling reduces instrumentation-
related infection in rabbit spines: a pilot study. Clin Orthop
Relat Res. 2012;470(6):1646–51. https ://doi.org/10.1007/s1199
9-011-2231-1.
52. Hu J, Qu J, Xu D, Zhang T, Qin L, Lu H. Combined applica-
tion of low-intensity pulsed ultrasound and functional electrical
stimulation accelerates bone-tendon junction healing in a rabbit
model. J Orthop Res. 2014;32(2):204–9. https ://doi.org/10.1002/
jor.22505 .
53. Kim J, Yang HJ, Cho TH, Lee SE, Park YD, Kim HM, etal.
Enhanced regeneration of rabbit mandibular defects through a
combined treatment of electrical stimulation and rhBMP-2 appli-
cation. Med Biol Eng Comput. 2013;51(12):1339–48. https ://doi.
org/10.1007/s1151 7-013-1106-x.
54. Matsumoto H, Ochi M, Abiko Y, Hirose Y, Kaku T, Sakagu-
chi K. Pulsed electromagnetic fields promote bone formation
around dental implants inserted into the femur of rabbits. Clin
Oral Implant Res. 2000;11(4):354–60.
55. Ottani V, Raspanti M, Martini D, Tretola G, Ruggeri A, Franchi
M, etal. Electromagnetic stimulation on the bone growth using
backscattered electron imaging. Micron. 2002;33:121–5.
56. Rubinacci A, Black J, Brighton CT, Friedenberg ZB. Changes
in bioelectric potentials on bone associated with direct current
stimulation of osteogenesis. J Orthop Res. 1988;6:335–45.
57. Shafer DM, Rogerson K, Norton L, Bennett J. The effect of
electrical perturbation on osseointegration of titanium dental
implants. J Oral Maxillofac Surg. 1995;53:1063–8.
58. Shimizu E, Matsuda-Honjyo Y, Samoto H, Saito R, Nakajima
Y, Nakayama Y, etal. Static magnetic fields-induced bone sialo-
protein (BSP) expression is mediated through FGF2 response
element and pituitary-specific transcription factor-1 motif. J Cell
Biochem. 2004;91:1183–96.
59. Smith R. Nagel D Effects of pulsing electromagnetic
fields on bone growth and articular cartilage. Clin Orthop.
1983;181:277–82.
60. Taylor BC, French BG, Fowler TT, Russell J, Poka A. Induced
membrane technique for reconstruction to manage bone loss. J
Am Acad Orthop Surg. 2012;20:142–50.
61. Veronesi F, Cadossi M, Giavaresi G, Martini L, Setti S, Buda R,
etal. Pulsed electromagnetic fields combined with a collagen-
ous scaffold and bone marrow concentrate enhance osteochon-
dral regeneration: an invivo study. BMC Musculoskelet Disord.
2015;2(16):233. https ://doi.org/10.1186/s1289 1-015-0683-2.
62. Yonemori K, Matsunaga S, Ishidou Y, Maeda S, Yoshida H.
Early effects of electrical stimulation on osteogenesis. Bone.
1996;19:173–80.
63. Zimmerman M, Parsons JR, Alexander H, Weiss AB. The elec-
trical stimulation of bone using a filamentous carbon cathode. J
Biomed Mater Res. 1984;18:927–38.
64. Berry JL, Geiger JM, Moran JM, Skraba JS, Greenwald AS. Use
of tricalcium phosphate or electrical-stimulation to enhance
the bone porous implant interface. J Biomed Mater Res.
1986;20:65–77.
65. Bins-Ely LM, Cordero EB, Souza JCM, Teughels W, Ben-
fatti CAM, Magini RS. Invivo electrical application on tita-
nium implants stimulating bone formation. J Periodontal Res.
2017;52(3):479–84. https ://doi.org/10.1111/jre.12413 .
66. Branham GB, Triplett RG, Yeandle S, Vieras F. The effect of
electrical current on the healing of mandibular freeze-dried bone
allografts in dogs. J Oral Maxillofac Surg. 1985;43(6):403–7.
67. Chakkalakal DA, Lippiello L, Shindell RL, Connolly JF. Elec-
trophysiology of direct current stimulation of fracture healing in
canine radius. IEEE Trans Biomed Eng. 1990;37:1048–58.
68. Colella SM, Miller AG, Stang RG, Stoebe TG, Spengler DM.
Fixation of porous titanium implants in cortical bone enhanced
by electrical stimulation. J Biomed Mater Res. 1981;15:37–46.
69. Connolly JF, Henry H, Jardon J. The Electrical Enhancement of
Periosteal Proliferation in Normal and Delayed Fracture Healing.
Clin Orthop. 1977;124:97–105.
70. Dejardin LM, Kahanovitz N, Arnoczky SP, Simon BJ. The effect
of varied electrical current densities on lumbar spinal fusions in
dogs. Spine J. 2001;1:341–7.
71. Doyle ND. Rehabilitation of fractures in small animals: maxi-
mize outcomes, minimize complications. Clin Tech Small Anim
Pract. 2004;19:180–91.
72. Rodriguez Fuentes AE, Marcondes de Souza JP, Valeri V,
Mascarenhas S. Experimental model of electric stimulation of
pseudarthrosis healing. Clin Orthop. 1984;183:267–75.
73. Inoue N, Ohnishi I, Chen D, Deitz LW, Schwardt JD, Chao
EYS. Effect of pulsed electromagnetic fields (PEMF) on late-
phase osteotomy gap healing in a canine tibial model. J Orthop
Res. 2002;20:1106–14.
74. Jacobs JD, Norton LA. Electrical stimulation of osteogenesis
in periodontal defects. Clin Orthop. 1977;124:41–52.
M.B.Bhavsar et al.
1 3
75. Jacobs RR, Luethi U, Dueland RT, Perren SM. Electrical
stimulation of experimental nonunions. Clin Orthop Relat Res.
1981;161:146–53.
76. Kahanovitz N, Arnoczky S, Nemzek J, Shores A. The effect of
EMF pulsing on posterior lumbar spinal fusion in dogs. Spine.
1994;19:705–9.
77. Lindsey RW, Grobman J, Leggon RE, Panjabi M, Fried-
laender GE. Effects of bone graft and electrical stimulation
on the strength of healing bony defects in dogs. Clin Orthop.
1987;222:275–80.
78. Modarresi J, Aghili H, Karandish M, Jalali B, Zahir ST. Effect
of direct electric current on parietal bone osteogenesis. J
Craniofac Surg. 2012;23(6):1607–9. https ://doi.org/10.1097/
SCS.0b013 e3182 57542 3.
79. Ortman LF, Casey DM, Deers M. Bioelectric stimulation and
residual ridge resorption. J Prosthet Dent. 1992;67:67–71.
80. Dev MED, Org ART, Ingrowth T, Recum V, Al PET.
ABSTRACT The effect of electrical stimulation on the inter-
facial strength of the porous polymethylmethacrylate implant/
oral tissue union and the amount. Department of Interdisci-
plinary Studies, College of Engineering Clemson University
Clemson, 1978;6:291–303.
81. Cundy PJ, Paterson DC. A ten year review of treatment of
delayed union and nonunion with an implanted bone growth
stimulator. Clin Orthop Relat Res. 1988;259:216–22.
82. Paterson DC, Hillier TM, Carter RF, Ludbrook J, Maxwell
GM, Savage JP. Experimental delayed union of the dog tibia
and its use in assessing the effect of an electrical bone growth
stimulator. Clin Orthop. 1977;128:340–50.
83. Paterson DC, Carter RF, Tilbury RF, Ludbrook J. Savage JP
The effects of varying current levels of electrical stimulation.
Clin Ortho Relat Res. 1982;169:303–12.
84. Pepper JR, Herbert MA, Anderson JR, Bobechko WP. Effect of
capacitive coupled electrical stimulation on regenerate bone. J
Orthop Res. 1996;14:296–302.
85. Schutzer SF, Jasty M, Bragdon CR, Harrigan TP, Harris WH.
A double-blind study on the effects of a capacitively coupled
electrical field on bone ingrowth into porous-surfaced canine
total hip prosthesis. Clin Orthop Rel Res. 1990;260:297–304.
86. Shayesteh YS, Eslami B, Dehghan MM, Vaziri H, Alikhassi
M, Mangoli A, etal. The effect of a constant electrical field
on osseointegration after immediate implantation in dog man-
dibles: a preliminary study: basic science research. J Prostho-
dont. 2007;16:337–42.
87. Shokry M. Preliminary study on the use of a silver oxide watch
battery (1.5V) for electrical enhancement of bone healing. Vet
Res Commun. 1985;9:245–50.
88. Srivastava KP, Lahiri V, Khare A. Chandra H Histomorpho-
logic evidence of fracture healing after direct electrical stimu-
lation in dogs. J Trauma. 1982;22(9):785–6.
89. Atalay Y, Gunes N, Guner MD, Akpolat V, Celik MS, Guner R.
Pentoxifylline and electromagnetic field improved bone frac-
ture healing in rats. Drug Des Dev Ther. 2015;9(9):5195–201.
https ://doi.org/10.2147/DDDT.S8966 9.
90. Brighton CT, Tadduni GT, Goll SR, Pollack SR. Treatment of
denervation/disuse osteoporosis in the rat with a capacitively
coupled electrical signal: effects on bone formation and bone
resorption. J Orthop Res. 1988;6:676–84.
91. Giannunzio GA, Speerli RC, Guglielmotti MB. Electrical field
effect on peri-implant osteogenesis: a histologic and histomor-
phometric study. Implant Dent. 2008;17:118–26.
92. Guizzardi S, Silvestre M, Govoni P, Scandroglio R. Pulsed elec-
tromagnetic field stimulation on posterior spinal fusions: a his-
tological study in rats. J Spinal Disord. 1994;7:36–40.
93. Van Der Jagt OP, Van Der Linden JC, Waarsing JH, Verhaar JAN,
Weinans H. Systemic treatment with pulsed electromagnetic
fields do not affect bone microarchitecture in osteoporotic rats.
Int Orthop. 2012;36(7):1501–6. https ://doi.org/10.1007/s0026
4-011-1471-8.
94. Lirani-Galvão APR, Bergamaschi CT, Silva OL, Lazaretti-Castro
M. Electrical field stimulation improves bone mineral density in
ovariectomized rats. Braz J Med Biol Res. 2006;39:1501–5.
95. Manjhi J, Mathur R, Behari J. Effect of low level capacitive-
coupled pulsed electric field stimulation on mineral profile
of weight-bearing bones in ovariectomized rats. J Biomed
Mater Res B Appl Biomater. 2010;92(1):189–95. https ://doi.
org/10.1002/jbm.b.31505 .
96. Marino AA, Cullen JM, Reichmanis M, Becker RO. Fracture
healing in rats exposed to extremely low frequency electric fields.
Clin Orthop 1979;145:239–44.
97. Medalha CC, Amorim BO, Ferreira JM, Oliveira P, Pereira RMR,
Tim C, etal. Comparison of the effects of electrical field stimu-
lation and low-level laser therapy on bone loss in spinal cord-
injured rats. Photomed Laser Surg. 2010;28(5):669–74. https ://
doi.org/10.1089/pho.2009.2691.
98. Nakajima M, Inoue M, Hojo T, Inoue N, Tanaka K, Takatori R,
etal. Effect of electroacupuncture on the healing process of tibia
fracture in a rat model: a randomised controlled trial. Acupunct
Med. 2010;28:140–3.
99. Puricelli E, Dutra NB, Ponzoni D. Histological evaluation
of the influence of magnetic field application in autogenous
bone grafts in rats. Head Face Med. 2009;5:1. https ://doi.
org/10.1186/1746-160X-5-1.
100. Shen WW, Zhao JH. Pulsed electromagnetic fields stimulation
affects BMD and local factor production of rats with disuse
osteoporosis. Bioelectromagnetics. 2010;31(2):113–9. https ://
doi.org/10.1002/bem.20535 .
101. Spadaro JA, Becker RO. Function of implanted cathodes
in electrode-induced bone growth. Med Biol Eng Comput.
1979;17:769–75.
102. Takano-Yamamoto T, Kawakami M, Sakuda M. Effect of a puls-
ing electromagnetic field on demineralized bone-matrix-induced
bone formation in a bony defect in the premaxilla of rats. J Dent
Res. 1992;71:1920–5.
103. Tomofuji T, Ekuni D, Azuma T, Irie K, Endo Y, Kasuyama
K, etal. Effects of electrical stimulation on periodontal tissue
remodeling in rats. J Periodontal Res. 2013;48(2):177–83. https
://doi.org/10.1111/j.1600-0765.2012.01518 .x.
104. Uysal T, Amasyali M, Olmez H, Karslioglu Y, Gunhan O.
Stimulation of bone formation by direct electrical current in
an orthopedically expanded suture in the rat. Korean J Orthod.
2010;40:106–14.
105. Yang BY, Huang TC, Chen YS, Yao CH. Reconstructive effects
of percutaneous electrical stimulation combined with GGT
composite on large bone defect in rats. Evid Based Complement
Altern Med. 2013. https ://doi.org/10.1155/2013/60720 1.
106. Yu K, Yoon YS, Jeon J. The effect of electrical stimulation com-
bined with foam dressing on ulcer healing in rats with spinal cord
injury. Adv Skin Wound Care. 2015;28(11):495–502. https ://doi.
org/10.1097/01.ASW.00004 70553 .85257 .84.
107. Zamarioli A, Battaglino RA, Morse LR, Sudhakar S, Maranho
DAC, Okubo R, etal. Standing frame and electrical stimulation
therapies partially preserve bone strength in a rodent model of
acute spinal cord injury. Am J Phys Med Rehabil. 2013;92(5):402–
10. https ://doi.org/10.1097/PHM.0b013 e3182 87697 c.
108. Benazzo F, Cadossi M, Cavani F, Fini M, Giavaresi G, Setti
S, etal. Cartilage repair with osteochondral autografts in
sheep: effect of biophysical stimulation with pulsed electro-
magnetic fields. J Orthop Res. 2008;26(5):631–42. https ://doi.
org/10.1002/jor.20530 .
109. Dergin G, Aktas M, Gürsoy B, Kürkçü M, Devecioğlu Y,
Benlidayı E. Direct current electric stimulation in implant
Electrical stimulation-based bone fracture treatment, ifit works sowell why donotmore surgeons…
1 3
osseointegration: an experimental animal study with sheep.
J Oral Implantol. 2013;39(6):671–9. https ://doi.org/10.1563/
AAID-JOI-D-10-00172 .
110. Flouty OE, Oya H, Kawasaki H, Reddy CG, Fredericks DC,
Gibson-Corley KN, etal. Intracranial somatosensory responses
with direct spinal cord stimulation in anesthetized sheep.
PLoS One. 2013;8(2):e56266. https ://doi.org/10.1371/journ
al.pone.00562 66.
111. El-Hakim IE, Azim AM, El-Hassan MF, Maree SM. Prelimi-
nary investigation into the effects of electrical stimulation on
mandibular distraction osteogenesis in goats. Int J Oral Maxil-
lofac Surg. 2004;33(1):42–7.
112. Law HT, Annan I, McCarthy ID, Hughes SP, Stead AC, Cam-
burn MA, etal. The effect of induced electric currents on
bone after experimental osteotomy in sheep. J Bone Jt Surg
Br. 1985;67:463–9.
113. Muttini A, Abate M, Bernabò N, Cavani F, Mingozzi R, Tosi
U, etal. Effect of electric current stimulation in combination
with external fixator on bone healing in a sheep fracture model.
Vet Ital. 2014;50(4):249–57. https ://doi.org/10.12834 /VetIt
.271.963.
114. Toth JM, Seim HB, Schwardt JD, Humphrey WB, Wallskog JA,
Turner AS. Direct current electrical stimulation increases the
fusion rate of spinal fusion cages. Spine. 2000;25:2580–7.
115. Canè V, Botti P, Farneti D, Soana S. Electromagnetic stimula-
tion of bone repair: a histomorphometric study. J Orthop Res.
1991;9:908–17.
116. Kold SE, Hickman J. Preliminary study of quantitative aspects
and the effect of pulsed electromagnetic field treatment on the
incorporation of equine cancellous bone graft. Equine Vet J.
1987;19(2):120–4.
117. Sanders-Shamis M, Bramlage LR, Weisbrode SE, Gabel AA. A
preliminary investigation of the effect of selected electromag-
netic field devices on healing of cannon bone osteotomies in
horses. Equine Vet J. 1989;21:201–5.
118. Abeed RI, Naseer M, Abel EW. Capacitively coupled electrical
stimulation treatment: results from patients with failed long bone
fracture unions. J Orthop Trauma. 1998;12:510–3.
119. Adie S, Harris I, Naylor J. Pulsed electromagnetic field stimula-
tion for acute tibial shaft fractures: a multicenter, double-blind,
randomized trial. J Bone Jt Surg Am. 2011;93(17):1569–76.
https ://doi.org/10.2106/JBJS.J.00869 .
120. Andersen T, Christensen FB, Egund N, Ernst C, Fruensgaard S,
Ostergaard J, etal. The effect of electrical stimulation on lumbar
spinal fusion in older patients: a randomized, controlled, multi-
center trial: part 2: fusion rates. Spine. 2009;34:2248–53.
121. Andersen T, Christensen FB, Langdahl BL, Ernst C, Fru-
ensgaard S, Østergaard J, etal. Fusion mass bone qual-
ity after uninstrumented spinal fusion in older patients. Eur
Spine J. 2010;19(12):2200–8. https ://doi.org/10.1007/s0058
6-010-1373-2.
122. Assiotis A, Sachinis NP, Chalidis BE. Pulsed electromagnetic
fields for the treatment of tibial delayed unions and nonunions A
prospective clinical study and review of the literature. J Orthop
Surg Res. 2012;7:24. https ://doi.org/10.1186/1749-799x-7-24.
123. Bassett CA, Mitchell SN, Gaston SR. Treatment of ununited
tibial diaphyseal fractures with pulsing electromagnetic fields.
J Bone Jt Surg Am. 1981;63:511–23.
124. Beck BR, Matheson GO, Bergman G, Norling T, Fredericson
M, Hoffman AR, etal. Do capacitively coupled electric fields
accelerate tibial stress fracture healing? A randomized controlled
trial. Am J Sports Med. 2008;36(3):545–53.
125. Benazzo F, Mosconi M, Beccarisi G, Galli U. Use of capacitive
coupled electric fields in stress fractures in athletes. Clin Orthop
Relat Res. 1995;310:145–9.
126. Boyette MY, Herrera-Soto JA. Treatment of delayed and nonu-
nited fractures and osteotomies with pulsed electromagnetic field
in children and adolescents. Orthopedics. 2012;35(7):e1051–5.
https ://doi.org/10.3928/01477 447-20120 621-20.
127. Bronner S, Novella T, Becica L. Management of a delayed-
union sesamoid fracture in a dancer. J Orthop Sports Phys Ther.
2007;37:529–40.
128. Capanna R, Donati D, Masetti C, Manfrini M, Panozzo A,
Cadossi R, etal. Effect of electromagnetic fields on patients
undergoing massive bone graft following bone tumor resection.
A double blind study. Clin Orthop Rel Res. 1994;306:213–21.
129. de Haas WG, Watson J, Morrison DM. Non-invasive treatment
of ununited fractures of the tibia using electrical stimulation. J
Bone Jt Surg Br. 1980;62:465–70.
130. Donley BG, Ward DM. Implantable electrical stimulation in
high-risk hindfoot fusions. Foot Ankle Int. 2002;23:13–8.
131. Dunn A, Rush G. Electrical stimulation in treatment of delayed
union and nonunion of fractures and osteotomies. South Med J.
1984;77:1530–4.
132. Foley K, Mroz T, Arnold P. Randomized, prospective, and con-
trolled clinical trial of pulsed electromagnetic field stimulation
for cervical fusion. Spine J. 2008;8:436–42.
133. Fourie JA, Bowerbank P. Stimulation of bone healing in new
fractures of the tibial shaft using interferential currents. Physi-
other Res Int. 1997;2:255–68.
134. Freedman LS. Pulsating electromagnetic fields in the treatment of
delayed and non-union of fractures: results from a district general
hospital. Injury. 1985;16:315–7.
135. Garland D, Holt P, Harrington JT, Caldwell J, Zizic T, Cholew-
czynski J. A 3-month, randomized, double-blind, placebo-
controlled study to evaluate the safety and efficacy of a highly
optimized, capacitively coupled, pulsed electrical stimulator
in patients with osteoarthritis of the knee. Osteoarthr Cartil.
2007;15(6):630–7.
136. Goodwin C, Brighton C, Guyer R, Johnson J, Light K, Yuan H. A
double blind study of capacitively coupled electrical stimulation
as an adjunct to lumbar spinal fusion. Spine. 1999;24:1349–57.
137. Hanft JR, Goggin JP, Landsman A, Surprenant M. The role of
combined magnetic field bone growth stimulation as an adjunct
in the treatment of neuroarthropathy/Charcot joint: an expanded
pilot study. J Foot Ankle Surg. 1998;37:510–5.
138. Hannemann P, Göttgens KW, van Wely BJ, Kolkman KA, Werre
AJ, Poeze M, etal. Pulsed electromagnetic fields in the treatment
of fresh scaphoid fractures. A multicenter, prospective, double
blind, placebo controlled, randomized trial. BMC Musculoskelet
Disord. 2011;12:90. https ://doi.org/10.1186/1471-2474-12-90.
139. Hannemann PFW, Göttgens KWA, van Wely BJ, Kolkman KA,
Werre AJ, Poeze M, etal. The clinical and radiological outcome
of pulsed electromagnetic field treatment for acute scaphoid frac-
tures: a randomised double-blind placebo-controlled multicentre
trial. J Bone Jt Surg Br. 2012;94(10):1403–8.
140. Holmes GB. Treatment of delayed unions and nonunions of the
proximal fifth metatarsal with pulsed electromagnetic fields. Foot
Ankle Int. 1994;15:552–6.
141. Ito H, Shirai Y. The efficacy of ununited tibial fracture treat-
ment using pulsing electromagnetic fields: relation to bio-
logical activity on nonunion bone ends. J Nippon Med Sch.
2001;68(2):149–53.
142. Itoh S, Ohta T, Sekino Y, Yukawa Y, Shinomiya K. Treatment of
distal radius fractures with a wrist-bridging external fixation: the
value of alternating electric current stimulation. J Hand Surg Eur.
2008;33(5):605–8. https ://doi.org/10.1177/17531 93408 09225 3.
143. Jenis L, Howard S, Rebecca S, Brett Y. Prospective comparison
of the effect of direct current electrical stimulation and pulsed
M.B.Bhavsar et al.
1 3
electromagnetic fields on instrumented posteolateral lumbar
arthrodesis. Spinal Disord. 2000;13:290–6.
144. Jorgensen TE. Electrical stimulation of human fracture healing
by means of a slow pulsating, asymmetrical direct current. Clin
Orthop Rel R. 1977;124:127.
145. Kahn J. Transcutaneous electrical nerve stimulation for nonu-
nited fractures; a clinical report. Phys Ther. 1982;62:840–4.
146. Kane WJ. Direct current electrical bone growth stimulation for
spinal fusion. Spine. 1988;13:363–5.
147. Kucharzyk D. A controlled prospective outcome study of
implantable electrical stimulation with spinal instrumentation
in a high risk spinal fusion population. Spine. 1999;24:465–68.
148. Lazovic M, Kocic M, Dimitrijevic L, Stankovic I, Spalevic M,
Ciric T. Pulsed electromagnetic field during cast immobilization
in postmenopausal women with Colles’ fracture. Srp Arh Celok
Lek. 2012;140(9–10):619–24.
149. Linovitz R, Pathria M, Bernhardt M, Green D, Law M, McGuire
R, etal. Combined magnetic fields accelerate and increase spine
fusion: a double-blind, randomized, placebo controlled study.
Spine. 2002;27:1383–9.
150. Livesley PJ, Mugglestone A, Whitton J. Electrotherapy and the
management of minimally displaced fracture of the neck of the
humerus. Injury. 1992;23:323–6.
151. Madronero A, Pitillas I, Manso FJ. Pulsed electromagnetic field
treatment failure in radius non-united fracture healing. J Biomed
Eng. 1988;10:463–6.
152. Mammi GI, Rocchi R, Cadossi R, etal. The electrical stimula-
tion of tibial osteotomies: A double-blind study. Clin Orthop.
1993;288:246–53.
153. Marks RA. Spine fusion for discogenic low back pain: outcomes
in patients treated with or without pulsed electromagnetic field
stimulation. Adv Ther. 2000;17:57–67.
154. Martinez-Rondanelli A, Martinez JP, Moncada ME, Manzi E,
Pinedo CR, Cadavid H. Electromagnetic stimulation as coadju-
vant in the healing of diaphyseal femoral fractures: a randomized
controlled trial. Colomb Med (Cali). 2014;45(2):67–71.
155. Massari L, Fini M, Cadossi R. Biophysical stimulation with
pulsed electromagnetic fields in osteonecrosis of the femoral
head. J Bone Jt Surg Am. 2006;88:56–60.
156. Masureik C, Eriksson C. Preliminary clinical evaluation of the
effect of small electrical currents on the healing of jaw fractures.
Clin Orthop Relat R. 1977;124:84–91.
157. Meskens M, Stuyck J, Mulier J. Treatment of delayed union and
nonunion of the tibia by pulsed electromagnetic fields. Bull Hosp
Jt Dis Orthop Inst. 1988;48:170–5.
158. Paterson D, Simonis RB. Electrical stimulation in the treatment
of congenital pseudoarthrosis of the tibia. J Bone Jt Surg Br.
1985;67:454–62.
159. Punt BJ, Den Hoed PT, Fontijne WPJ. Pulsed electromagnetic
fields in the treatment of nonunion. Eur J Orthop Surg Traumatol.
2008;18:127–33.
160. Reilingh ML, van Bergen CJA, Gerards RM, van Eekeren IC,
de Haan RJ, Sierevelt IN, etal. Effects of pulsed electromag-
netic fields on return to sports after arthroscopic debridement
and microfracture of osteochondral talar defects: a randomized,
double-blind, placebo-controlled, multicenter trial. Am J Sports
Med. 2016;44(5):1292–300. https ://doi.org/10.1177/03635 46515
62654 4.
161. Rogozinski A, Rogozinski C. Efficacy of implanted bone growth
stimulation in instrumented lumbosacral spinal fusion. Spine.
1996;21:2479–483.
162. Saltzman C, Lightfoot A, Amendola A. PEMF as treatment for
delayed healing of foot and ankle arthrodesis. Foot Ankle Int.
2004;25:771–3.
163. Scott G, King JB. A prospective, double-blind trial of electrical
capacitive coupling in the treatment of non-union of long bones.
J Bone Jt Surg Am. 1994;76:820–6.
164. Shi H, Xiong J, Chen Y, Wang J, Qiu X, Wang Y, etal. Early
application of pulsed electromagnetic field in the treatment of
postoperative delayed union of long-bone fractures: a prospec-
tive randomized controlled study. BMC Musculoskelet Disord.
2013;14:35. https ://doi.org/10.1186/1471-2474-14-35.
165. Simmons JW. Treatment of failed posterior lumbar interbody
fusion (PLIF) of the spine with pulsing electromagnetic fields.
Clin Orthop Relat Res. 1985;183:127.
166. Simmons JW, Mooney V, Thacker I. Pseudarthrosis after lumbar
spine fusion: nonoperative salvage with pulsed electromagnetic
fields. Am J Orthop. 2004;33:27–30.
167. Streit A, Watson BC, Granata JD, Philbin TM, Lin H-N,
O’Connor JP, etal. Effect on clinical outcome and growth factor
synthesis with adjunctive use of pulsed electromagnetic fields
for fifth metatarsal nonunion fracture: a double-blind rand-
omized study. Foot Ankle Int. 2016;37(9):919–23. https ://doi.
org/10.1177/10711 00716 65262 1.
168. Steinberg ME, Brighton CT, Bands RE, Hartman KM. Capacitive
coupling as an adjunctive treatment for avascular necrosis. Clin
Orthop Relat Res. 1990;261:11–8.
169. van Bergen CJA, Blankevoort L, de Haan RJ, Sierevelt IN,
Meuffels DE, d’Hooghe PRN, etal. Pulsed electromagnetic
fields after arthroscopic treatment for osteochondral defects
of the talus: double-blind randomized controlled multicenter
trial. BMC Musculoskelet Disord. 2009;10:83. https ://doi.
org/10.1186/1471-2474-10-83.
170. Wahlstrom O, Knutsson H. A device for generation of elec-
tromagnetic fields of extremely low frequency. J Biomed Eng.
1984;6:293–6.
171. Welch WC, Willis SL, Gerszten PC. Implantable direct cur-
rent stimulation in para-axial cervical arthrodesis. Adv Ther.
2004;21:389–400.
... Furthermore, based on the findings of the piezoelectrical properties of bone, invasive and non-invasive electromagnetic osteostimulation (E-Stim) was established for the treatment of pseudarthroses and ONFH in the last decades [11][12][13][14][15][16][17][18][19] . In contrast to external noninvasive E-Stim, invasive E-Stim provides electrical stimulation directly to the bone independently of the surrounding tissue 13,17,18 . ...
... Furthermore, based on the findings of the piezoelectrical properties of bone, invasive and non-invasive electromagnetic osteostimulation (E-Stim) was established for the treatment of pseudarthroses and ONFH in the last decades [11][12][13][14][15][16][17][18][19] . In contrast to external noninvasive E-Stim, invasive E-Stim provides electrical stimulation directly to the bone independently of the surrounding tissue 13,17,18 . However, a significant amount months after inclusion of the last patient. ...
Article
The study aimed to evaluate the outcomes of osteonecrosis of the femoral head (ONFH) in adults after surgical treatment including invasive electromagnetic osteostimulation (E-Stim). Further, the influence of disease stage and several comorbidities on the joint preservation rate should be examined. Sixty patients (66 hip joints) with ONFH were included in this retrospective cross-sectional analysis (mean follow-up: 58 months, 19-110 months). Potential ONFH risk factors and comorbidities (ONFH stage, age, sex, alcohol, smoking, cortisone medication, chemotherapy) were recorded. The influence of specific parameters on the joint preservation rates was evaluated by a multivariate logistic regression analysis. Finally, patients with preserved hip joints underwent an assessment of their last available X-rays. The joint preservation rate depended on the initial ONFH Steinberg stage (I+II: 82.8%, III: 70.8%, ≥ IVa: 38.5%). Initially collapsed ONFH (p ≤ 0.001) and cortisone therapy (p = 0.004) significantly decreased the joint preservation rates. In case of progressed ONFH, the presence of ≥ 2 risk factors resulted in higher THA conversion rates (stage III: OR 18.8; stage ≥IVa: OR 12). In 94% of the available X-rays, the ONFH stage improved or did not progress. No complications could be attributed to the E-Stim device or procedure. The present surgical protocol including minimally invasive E-Stim revealed high joint preservation rates for non-collapsed ONFH after mid-term postoperative follow-up. Especially in progressed ONFH, the-risk profile seems to be crucial and hence, for joint preserving surgery, careful patient selection is recommended.
... Since the 1930s, with the advancement of modern medicine, EStim therapy has been substantiated as an effective approach for treating severe mood and psychotic disorders [156], bone fracture [157], and various neuromuscular pain [13,14,158]. However, some clinical trials and fundamental research have yielded diverse conclusions regarding EStim therapy [159][160][161]. This could be due to the high heterogeneity in the parameters of electrical stimulation used in these studies. ...
... Considering that electric stimulation has demonstrated its potential to enhance bone fracture healing in animal and clinical experiment, its application in maxillofacial surgery has gradually emerged over the past decade. While exogenous electric stimulation usually requires an external electric source and wires, these devices connected to the maxillofacial surgical area can interfere with patients' daily activities and reduce compliance [159]. Even though those devices can be intraorally placed, the oral environment may cause the electric source corruption and the release of toxic chemical substances. ...
Article
Full-text available
Background Bioelectric signals, whether exogenous or endogenous, play crucial roles in the life processes of organisms. Recently, the significance of bioelectricity in the field of dentistry is steadily gaining greater attention. Objective This narrative review aims to comprehensively outline the theory, physiological effects, and practical applications of bioelectricity in dental medicine and to offer insights into its potential future direction. It attempts to provide dental clinicians and researchers with an electrophysiological perspective to enhance their clinical practice or fundamental research endeavors. Methods An online computer search for relevant literature was performed in PubMed, Web of Science and Cochrane Library, with the keywords “bioelectricity, endogenous electric signal, electric stimulation, dental medicine.” Results Eventually, 288 documents were included for review. The variance in ion concentration between the interior and exterior of the cell membrane, referred to as transmembrane potential, forms the fundamental basis of bioelectricity. Transmembrane potential has been established as an essential regulator of intercellular communication, mechanotransduction, migration, proliferation, and immune responses. Thus, exogenous electric stimulation can significantly alter cellular action by affecting transmembrane potential. In the field of dental medicine, electric stimulation has proven useful for assessing pulp condition, locating root apices, improving the properties of dental biomaterials, expediting orthodontic tooth movement, facilitating implant osteointegration, addressing maxillofacial malignancies, and managing neuromuscular dysfunction. Furthermore, the reprogramming of bioelectric signals holds promise as a means to guide organism development and intervene in disease processes. Besides, the development of high-throughput electrophysiological tools will be imperative for identifying ion channel targets and precisely modulating bioelectricity in the future. Conclusions Bioelectricity has found application in various concepts of dental medicine but large-scale, standardized, randomized controlled clinical trials are still necessary in the future. In addition, the precise, repeatable and predictable measurement and modulation methods of bioelectric signal patterns are essential research direction. Graphical abstract
... When an electric stimulation or an external mechanical force is applied, CFs and HAP separate and become polarization. Studies on animals and in clinical settings have shown that the externally given ESs promote bone repair [165]. By activating calcium-calmodulin which upregulates the cytokines such as BMP and TGF-β, ESs can promote osteogenesis [166,167]. ...
Article
Full-text available
Microcarrier applications have made great advances in tissue engineering in recent years, which can load cells, drugs, and bioactive factors. These microcarriers can be minimally injected into the defect to help reconstruct a good microenvironment for tissue repair. In order to achieve more ideal performance and face more complex tissue damage, an increasing amount of effort has been focused on microcarriers that can actively respond to external stimuli. These microcarriers have the functions of directional movement, targeted enrichment, material release control, and providing signals conducive to tissue repair. Given the high controllability and designability of magnetic and electroactive microcarriers, the research progress of these microcarriers is highlighted in this review. Their structure, function and applications, potential tissue repair mechanisms, and challenges are discussed. In summary, through the design with clinical translation ability, meaningful and comprehensive experimental characterization, and in-depth study and application of tissue repair mechanisms, stimuli-responsive microcarriers have great potential in tissue repair.
... It was concluded that this negative electrical potential activity directly influenced osseous cells and the aggregation patterning of macromolecules in the extracellular matrix. 34 More than a decade of research has gone into electrically stimulating bone tissue to promote bone growth in nonunion fractures [35][36][37] and spinal fusions. 38 One example is using pulsed electromagnetic fields to prevent bone loss in immobilized patients. ...
Article
Full-text available
In tissue engineering, the pivotal role of scaffolds is underscored, serving as key elements to emulate the native extracellular matrix. These scaffolds must provide structural integrity and support and supply electrical, mechanical, and chemical cues for cell and tissue growth. Notably, electrical conductivity plays a crucial role when dealing with tissues like bone, spinal, neural, and cardiac tissues. However, the typical materials used as tissue engineering scaffolds are predominantly polymers, which generally characteristically feature poor electrical conductivity. Therefore, it is often necessary to incorporate conductive materials into the polymeric matrix to yield electrically conductive scaffolds and further enable electrical stimulation. Among different conductive materials, carbon nanomaterials have attracted significant attention in developing conductive tissue engineering scaffolds, demonstrating excellent biocompatibility and bioactivity in both in vitro and in vivo settings. This article aims to comprehensively review the current landscape of carbon‐based conductive scaffolds, with a specific focus on their role in advancing tissue engineering for the regeneration and maturation of functional tissues, emphasizing the application of electrical stimulation. This review highlights the versatility of carbon‐based conductive scaffolds and addresses existing challenges and prospects, shedding light on the trajectory of innovative conductive scaffold development in tissue engineering.
... Electrical stimulation (ES) has been clinically proven to be beneficial for stimulating osteogenesis and angiogenesis, alleviating inflammatory response and tuning macrophage polarization through improving mitochondrial function and inducing more ATP synthesis [18][19][20]. However, conventional electrical stimulation requires bulk devices, wired connections, and invasive and implantable electrodes [21,22]. As alveolar bone is periodically stress-bearing tissue, piezoelectric transducers offer a new solution to the dilemma [23][24][25]. ...
Article
Full-text available
The impaired differentiation ability of resident cells and disordered immune microenvironment in periodontitis pose a huge challenge for bone regeneration. Herein, we construct a piezoelectric hydrogel to rescue the impaired osteogenic capability and rebuild the regenerative immune microenvironment through bioenergetic activation. Under local mechanical stress, the piezoelectric hydrogel generated piezopotential that initiates osteogenic differentiation of inflammatory periodontal ligament stem cells (PDLSCs) via modulating energy metabolism and promoting adenosine triphosphate (ATP) synthesis. Moreover, it also reshapes an anti-inflammatory and pro-regenerative niche through switching M1 macrophages to the M2 phenotype. The synergy of tilapia gelatin and piezoelectric stimulation enhances in situ regeneration in periodontal inflammatory defects of rats. These findings pave a new pathway for treating periodontitis and other immune-related bone defects through piezoelectric stimulation-enabled energy metabolism modulation and immunomodulation.
... Various forms of electrical stimulation have been utilized for several years to expedite wound healing in both soft and hard tissues (13). Furthermore, they have found application in post-surgical pain and edema control, neuralgiform pain treatment in the craniofacial region, acute fracture management, correction of nonunion fractures, periodontal disease treatment, dental procedure anesthesia, and the management of chronic and acute pain in the maxillofacial region (14)(15)(16)(17). In recent years, they have also been employed to enhance the osseointegration of dental implants, thus reducing healing time, with ongoing research continually adding to the existing literature (18)(19)(20)(21). ...
Article
Full-text available
Introduction: Currently, one of the most promising research areas in dental implantology is the exploration of additional procedures to reduce loading time for implants and enhance osseointegration in cases of poor bone quality. Various techniques have been researched and developed for stimulating bone production, including electrical stimulation of the jawbone and surrounding tissues. However, there is limited research on the direct relationship between electrostimulation and osseointegration. This experimental study aims to investigate the effects of corona stimulation (CS) on the rate and quality of osseointegration, as well as its potential to reduce the waiting period for dental implants. Materials and Methods: In our experimental protocol, we inserted 32 dental implants into the tibia of four male sheep bilaterally. Implants on the right tibia of each male sheep underwent CS treatment, while the other side served as a control group without any stimulation. The animals were sacrificed on the 15th and 30th days after implantation. Bone segments containing the implants were processed using a noncalcified method. We assessed new bone formation and osseointegration around the dental implants using the undecalcified method and histomorphological analysis. An experienced blinded investigator measured percentages of mineralized bone-implant contact (BIC), bone area (BAr), and bone perimeter (BPm) to evaluate the bone-implant interface. Statistical analyses were performed using SPSS 21 for Windows, with a significance level set at p < 0.05. Results: The histomorphometric parameters revealed a significant increase in BIC, BAr, and BPm values in the CS group compared to the control group on both the 15th and 30th days (p < 0.05). There was no statistically significant difference in BIC ratio between the second and fourth stimulation groups. Conclusion: The findings of this experimental study suggest that CS may have a positive impact on the early osseointegration period of dental implants.
Article
Full-text available
Bone regeneration is a complex pathophysiological process determined by molecular, cellular, and biomechanical factors, including immune cells and growth factors. Fracture healing usually takes several weeks to months, during which patients are frequently immobilized and unable to work. As immobilization is associated with negative health and socioeconomic effects, it would be desirable if fracture healing could be accelerated and the healing time shortened. However, interventions for this purpose are not yet part of current clinical treatment guidelines, and there has never been a comprehensive review specifically on this topic. Therefore, this narrative review provides an overview of the available clinical evidence on methods that accelerate fracture healing, with a focus on clinical applicability in healthy patients without bone disease. The most promising methods identified are the application of axial micromovement, electromagnetic stimulation with electromagnetic fields and direct electric currents, as well as the administration of growth factors and parathyroid hormone. Some interventions have been shown to reduce the healing time by up to 20 to 30%, potentially equivalent to several weeks. As a combination of methods could decrease the healing time even further than one method alone, especially if their mechanisms of action differ, clinical studies in human patients are needed to assess the individual and combined effects on healing progress. Studies are also necessary to determine the ideal settings for the interventions, i.e., optimal frequencies, intensities, and exposure times throughout the separate healing phases. More clinical research is also desirable to create an evidence base for clinical guidelines. To make it easier to conduct these investigations, the development of new methods that allow better quantification of fracture-healing progress and speed in human patients is needed.
Article
Full-text available
The incidence of large bone and articular cartilage defects caused by traumatic injury is increasing worldwide; the tissue regeneration process for these injuries is lengthy due to limited self‐healing ability. Endogenous bioelectrical phenomenon has been well recognized to play an important role in bone and cartilage homeostasis and regeneration. Studies have reported that electrical stimulation (ES) can effectively regulate various biological processes and holds promise as an external intervention to enhance the synthesis of the extracellular matrix, thereby accelerating the process of bone and cartilage regeneration. Hence, electroactive biomaterials have been considered a biomimetic approach to ensure functional recovery by integrating various physiological signals, including electrical, biochemical, and mechanical signals. This review will discuss the role of endogenous bioelectricity in bone and cartilage tissue, as well as the effects of ES on cellular behaviors. Then, recent advances in electroactive materials and their applications in bone and cartilage tissue regeneration are systematically overviewed, with a focus on their advantages and disadvantages as tissue repair materials and performances in the modulation of cell fate. Finally, the significance of mimicking the electrophysiological microenvironment of target tissue is emphasized and future development challenges of electroactive biomaterials for bone and cartilage repair strategies are proposed.
Article
Full-text available
Naturally occurring electric fields are known to be morphogenetic cues and associated with growth and healing throughout mammalian and amphibian animals and the plant kingdom. Electricity in animals was discovered in the eighteenth century. Electric fields activate multiple cellular signaling pathways such as PI3K/PTEN, the membrane channel of KCNJ15/Kir4.2 and intracellular polyamines. These pathways are involved in the sensing of physiological electric fields, directional cell migration (galvanotaxis, also known as electrotaxis), and possibly other cellular responses. Importantly, electric fields provide a dominant and over-riding signal that directs cell migration. Electrical stimulation could be a promising therapeutic method in promoting wound healing and activating regeneration of chronic and non-healing wounds. This review provides an update of the physiological role of electric fields, its cellular and molecular mechanisms, its potential therapeutic value, and questions that still await answers.
Article
Full-text available
Background Electrical stimulation (ES) has a long history of successful use in the clinical treatment of refractory, non-healing bone fractures and has recently been proposed as an adjunct to bone tissue-engineering treatments to optimize their therapeutic potential. This idea emerged from ES’s demonstrated positive effects on stem cell migration, proliferation, differentiation and adherence to scaffolds, all cell behaviors recognized to be advantageous in Bone Tissue Engineering (BTE). In previous in vitro experiments we demonstrated that direct current ES, administered daily, accelerates Mesenchymal Stem Cell (MSC) osteogenic differentiation. In the present study, we sought to define the optimal ES regimen for maximizing this pro-osteogenic effect. Methods Rat bone marrow-derived MSC were exposed to 100 mV/mm, 1 hr/day for three, seven, and 14 days, then osteogenic differentiation was assessed at Day 14 of culture by measuring collagen production, calcium deposition, alkaline phosphatase activity and osteogenic marker gene expression. Results We found that exposing MSC to ES for three days had minimal effect, while seven and 14 days resulted in increased osteogenic differentiation, as indicated by significant increases in collagen and calcium deposits, and expression of osteogenic marker genes Col1a1, Osteopontin, Osterix and Calmodulin. We also found that cells treated with ES for seven days, maintained this pro-osteogenic activity long (for at least seven days) after discontinuing ES exposure. Discussion This study showed that while three days of ES is insufficient to solicit pro-osteogenic effects, seven and 14 days significantly increases osteogenic differentiation. Importantly, we found that cells treated with ES for only seven days, maintained this pro-osteogenic activity long after discontinuing ES exposure. This sustained positive osteogenic effect is likely due to the enhanced expression of RunX2 and Calmodulin we observed. This prolonged positive osteogenic effect, long after discontinuing ES treatment, if incorporated into BTE treatment protocols, could potentially improve outcomes and in doing so help BTE achieve its full therapeutic potential.
Article
Full-text available
Bone Tissue engineering (BTE) has recently been introduced as an alternative to conventional treatments for large non-healing bone defects. BTE approaches mimic autologous bone grafts, by combining cells, scaffold, and growth factors, and have the added benefit of being able to manipulate these constituents to optimize healing. Electrical stimulation (ES) has long been used to successfully treat non-healing fractures and has recently been shown to stimulate bone cells to migrate, proliferate, align, differentiate, and adhere to bio compatible scaffolds, all cell behaviors that could improve BTE treatment outcomes. With the above in mind we performed in vitro experiments and demonstrated that exposing Mesenchymal Stem Cells (MSC) + scaffold to ES for 3 weeks resulted in significant increases in osteogenic differentiation. Then in in vivo experiments, for the first time, we demonstrated that exposing BTE treated rat femur large defects to ES for 8 weeks, caused improved healing, as indicated by increased bone formation, strength, vessel density, and osteogenic gene expression. Our results demonstrate that ES significantly increases osteogenic differentiation in vitro and that this effect is translated into improved healing in vivo. These findings support the use of ES to help BTE treatments achieve their full therapeutic potential.
Article
Full-text available
BackgroundA substantial body of evidence supports the use of focused extracorporeal shock wave therapy (fESWT) in the non-invasive treatment of fracture nonunions. On the other hand, virtually no studies exist on the use of radial extracorporeal shock wave therapy (rESWT) for this indication. Methods We retrospectively analyzed 22 patients treated with rESWT for fracture nonunions of superficial bones that failed to heal despite initial surgical fixation in most cases. Radial extracorporeal shock wave therapy was applied without anesthesia in three rESWT sessions on average, with one rESWT session per week and 3000 radial extracorporeal shock waves at an energy flux density of 0.18 mJ/mm2 per session. Treatment success was monitored with radiographs and clinical examinations. ResultsSix months after rESWT radiographic union was confirmed in 16 out of 22 patients (73%), which is similar to the success rate achieved in comparable studies using fESWT. There were no side effects. The tibia was the most common treatment site (10/22) and 70% of tibia nonunions healed within 6 months after rESWT. Overall, successfully treated patients showed a mean time interval of 8.8 ± 0.8 (mean ± standard error of the mean) months between initial fracture and commencement of rESWT whereas in unsuccessfully treated patients the mean interval was 26.0 ± 10.1 months (p < 0.05). In unsuccessful tibia cases, the mean interval was 43.3 ± 13.9 months. Conclusions Radial extracorporeal shock wave therapy appears to be an effective and safe alternative in the management of fracture nonunions of superficial bones if diagnosed early and no fESWT device is available. The promising preliminary results of the present case series should encourage the implementation of randomized controlled trials for the early use of rESWT in fracture nonunions.
Article
Full-text available
Osteoporosis and its consequent fractures are a great social and medical problem mainly occurring in post-menopausal women. Effective forms of prevention and treatment of osteoporosis associated with lower costs and the least side effects are needed. Electrical fields are able to stimulate osteogenesis in fractures, but little is known about their action on osteoporotic tissue. The aim of the present study was to determine by bone densitometry the effects of electrical stimulation on ovariectomized female Wistar rats. Thirty rats (220 ± 10 g) were divided into three groups: sham surgery (SHAM), bilateral ovariectomy (OVX) and bilateral ovariectomy + electrical stimulation (OVX + ES). The OVX + ES group was submitted to a 20-min session of a low-intensity pulsed electrical field (1.5 MHz, 30 mW/cm²) starting on the 7th day after surgery, five times a week (total = 55 sessions). Global, spine and limb bone mineral density were measured by dual-energy X-ray absorptiometry (DXA Hologic 4500A) before surgery and at the end of protocol (84 days after surgery). Electrical stimulation improved (P
Article
Full-text available
Background Electrical stimulation (ES) has been successfully used to treat bone defects clinically. Recently, both cellular and molecular approaches have demonstrated that ES can change cell behavior such as migration, proliferation and differentiation. Methods In the present study we exposed rat bone marrow- (BM-) and adipose tissue- (AT-) derived mesenchymal stem cells (MSCs) to direct current electrical stimulation (DC ES) and assessed temporal changes in osteogenic differentiation. We applied 100 mV/mm of DC ES for 1 h per day for three, seven and 14 days to cells cultivated in osteogenic differentiation medium and assessed viability and calcium deposition at the different time points. In addition, expression of osteogenic genes, Runx2, Osteopontin, and Col1A2 was assessed in BM- and AT-derived MSCs at the different time points. Results Results showed that ES changed osteogenic gene expression patterns in both BM- and AT-MSCs, and these changes differed between the two groups. In BM-MSCs, ES caused a significant increase in mRNA levels of Runx2, Osteopontin and Col1A2 at day 7, while in AT-MSCs, the increase in Runx2 and Osteopontin expression were observed after 14 days of ES. Discussion This study shows that rat bone marrow- and adipose tissue-derived stem cells react differently to electrical stimuli, an observation that could be important for application of electrical stimulation in tissue engineering.
Article
Purpose: Treatment of scaphoid nonunion with a segmental defect presents a challenging clinical problem. Various techniques have been proposed, often involving structural grafting with vascularized and nonvascularized bone. The authors hypothesize that satisfactory clinical and radiographic outcomes are possible with a relatively simplified technique of volar plate fixation with autogenous, purely cancellous graft. Methods: The authors performed a retrospective review of 34 patients with scaphoid nonunions with segmental defects, treated with plate fixation and purely cancellous bone grafting. Cases with avascular necrosis were excluded. Surgical management included a volar incision, reduction, bone grafting from the ipsilateral distal radius and/or olecranon, and application of a volar locking plate. Postoperative outcome measures included time to union based on computed tomography, return to work and sports, patient-reported pain and disability scores, grip strength, and range of motion. Results: Thirty-four patients with an average age of 31 years (range, 16-55 years) were treated with volar plate fixation and cancellous grafting, an average of 34 months after initial injury. Twenty-six patients (76%) were treated for nonunion at the scaphoid waist, 7 (21%) at the proximal pole, and 1 (3%) at the distal pole. Mean final follow-up was 18.7 months (range, 12-34 months). When union was defined by computed tomography evidence of healing, 2 (6%) scaphoids healed by 6 weeks after surgery, 28 (82%) healed by 12 weeks, and 100% healed by 18 weeks. Mean Disabilities of the Arm, Shoulder, and Hand score improved from 27.1 ± 7.3 before surgery to 11.8 ± 5.8 after surgery. Grip strength, corrected for hand dominance, improved from 77.5% of the nonsurgical side before surgery to 90.5% after surgery. All employed patients returned to work, although 3 (9%) did not return to full capacity. Conclusions: The combination of scaphoid plate fixation and pure cancellous bone grafting for scaphoid nonunion with segmental defects yields reliable union rates and good patient outcomes. Autogenous cancellous grafting may be an alternative to more technically demanding or morbid grafting procedures for the treatment of scaphoid nonunion. Type of study/level of evidence: Therapeutic IV.
Article
Exogenous human neural progenitor cells (hNPCs) are promising stroke therapeutics, but optimal delivery conditions and exact recovery mechanisms remain elusive. To further elucidate repair processes and improve stroke outcomes, we developed an electrically conductive, polymer scaffold for hNPC delivery. Electrical stimulation of hNPCs alters their transcriptome including changes to the VEGF-A pathway and genes involved in cell survival, inflammatory response, and synaptic remodeling. In our experiments, exogenous hNPCs were electrically stimulated (electrically preconditioned) via the scaffold 1 day prior to implantation. After in vitro stimulation, hNPCs on the scaffold are transplanted intracranially in a distal middle cerebral artery occlusion rat model. Electrically preconditioned hNPCs improved functional outcomes compared to unstimulated hNPCs or hNPCs where VEGF-A was blocked during in vitro electrical preconditioning. The ability to manipulate hNPCs via a conductive scaffold creates a new approach to optimize stem cell-based therapy and determine which factors (such as VEGF-A) are essential for stroke recovery.
Article
One hundred and twenty-five patients with one hundred and twenty-seven ununited fractures of the tibial diaphysis were treated exclusively with pulsing electromagnetic fields. The over-all success rate in healing of the fracture with this surgically non-invasive out-patient method was 87 per cent. The success rate was not materially affected by the age or sex of the patient, the length of prior disability, the number of previous failed operations, or the presence of infection or metal fixation.
Article
Background and objective: The aim of the present in vivo study was to measure the bone implant contact area after electrical stimulation of dental implants. Material and methods: Ninety titanium dental implants (6 mm × 11.5 mm) with a smooth surface were placed in six male Beagle dogs and then the implant-bone interfaces was assessed by histological analyses after 7 and 15 d. The 12-month-old dogs, with a weight of 15 kg, were randomly divided into two groups based on the duration of bone healing: 7 and 15 d. Also, implants were divided into three groups based on electrical stimulation: group A, 10 μA; group B, 20 μA; and group C, control group. The electrical current was applied by an electrical device coupled to the implant connection. Results: After 7 days of electrical stimulation, no statistical differences in bone-implant interface contact area were observed. However, a significantly higher bone-implant interface contact area was recorded for group B than for groups A and C (p < 0.01) after 15 d. No statistical difference was observed between groups A and C (p > 0.05). Conclusion: The electrical stimulation of dental implants can generate a larger area of bone-implant interface contact as a result of bone formation. Factors such as different electrical current intensity and duration should be studied in further work to clarify the potential of this method. http://onlinelibrary.wiley.com/doi/10.1111/jre.12413/full